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A B S T R A C T
Background
Spinal anaesthesia has been implicated as one of the possible causes of neurological complications following surgical procedures. This
painful condition, occurring during the immediate postoperative period, is termed transient neurological symptoms (TNS) and is typically
observed aHer the use of spinal lidocaine. Alternatives to lidocaine that can provide high-quality anaesthesia without TNS development
are needed. This review was originally published in 2005, and last updated in 2009.
Objectives
To determine the frequency of TNS aHer spinal anaesthesia with lidocaine and compare it with other types of local anaesthetics by
performing a meta-analysis for all pair-wise comparisons, and conducting network meta-analysis (NMA) to rank interventions.
Search methods
We searched CENTRAL, MEDLINE, Elsevier Embase, and LILACS on 25 November 2018. We searched clinical trial registries and
handsearched the reference lists of trials and review articles.
Selection criteria
We included randomized and quasi-randomized controlled trials comparing the frequency of TNS aHer spinal anaesthesia with lidocaine
to other local anaesthetics. Studies had to have two or more arms that used distinct local anaesthetics (irrespective of the concentration
and baricity of the solution) for spinal anaesthesia in preparation for surgery.
We included adults who received spinal anaesthesia and considered all pregnant participants as a subgroup. The follow-up period for TNS
was at least 24 hours.
Data collection and analysis
Four review authors independently assessed studies for inclusion. Three review authors independently evaluated the quality of the
relevant studies and extracted the data from the included studies. We performed meta-analysis for all pair-wise comparisons of local
anaesthetics, as well as NMA.
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We used an inverse variance weighting for summary statistics and a random-eDects model as we expected methodological and clinical
heterogeneity across the included studies resulting in varying eDect sizes between studies of pair-wise comparisons. The NMA used all
included studies based on a graph theoretical approach within a frequentist framework. Finally, we ranked the competing treatments by
P scores.
Main results
The analysis included 24 trials reporting on 2226 participants of whom 239 developed TNS. Two studies are awaiting classification and one
is ongoing. Included studies mostly had unclear to high risk of bias.
The NMA included 24 studies and eight diDerent local anaesthetics; the number of pair-wise comparisons was 32 and the number of
diDerent pair-wise comparisons was 11. This analysis showed that, compared to lidocaine, the risk ratio (RR)  of TNS was  lower for
bupivacaine, levobupivacaine, prilocaine, procaine, and ropivacaine with RRs in the range of 0.10 to 0.23 while 2-chloroprocaine and
mepivacaine did not diDer in terms of RR of TNS development compared to lidocaine.
Pair-wise meta-analysis showed that compared with lidocaine, most local anaesthetics were associated with a reduced risk of TNS
development (except 2-chloroprocaine and mepivacaine) (bupivacaine: RR 0.16, 95% confidence interval (CI) 0.09 to 0.28; 12 studies;
moderate-quality evidence; 2-chloroprocaine: RR 0.09, 95% CI 0.01 to 1.51; 2 studies; low-quality evidence; levobupivacaine: RR 0.13, 95%
CI 0.02 to 0.69; 2 studies; low-quality evidence; mepivacaine: RR 1.01, 95% CI 0.18 to 5.82; 4 studies; very low-quality evidence; prilocaine:
RR 0.18, 95% CI 0.07 to 0.49; 4 studies; moderate-quality evidence; procaine: RR 0.14, 95% CI 0.04 to 0.52; 2 studies; moderate-quality
evidence; ropivacaine: RR 0.10, 95% CI 0.01 to 0.78; 2 studies; low-quality evidence).
We were unable to perform any of our planned subgroup analyses due to the low number of TNS events.
Authors' conclusions
Results from both NMA and pair-wise meta-analysis indicate that the risk of developing TNS aHer spinal anaesthesia is lower when
bupivacaine, levobupivacaine, prilocaine, procaine, and ropivacaine are used compared to lidocaine. The use of 2-chloroprocaine and
mepivacaine had a similar risk to lidocaine in terms of TNS development aHer spinal anaesthesia.
Patients should be informed of TNS as a possible adverse eDect of local anaesthesia with lidocaine and the choice of anaesthetic agent
should be based on the specific clinical context and parameters such as the expected duration of the procedure and the quality of
anaesthesia.
Due to the very low- to moderate-quality evidence (GRADE), future research eDorts in this field are required to assess alternatives to
lidocaine that would be able to provide high-quality anaesthesia without TNS development. The two studies awaiting classification and
one ongoing study may alter the conclusions of the review once assessed.
P L A I N   L A N G U A G E   S U M M A R Y
Occurrence of transient neurological symptoms following spinal anaesthesia with lidocaine versus other local anaesthetics in
adults undergoing surgery
Review question
We aimed to determine if transient neurological symptoms (TNS) occur more frequently aHer recovery from spinal anaesthesia with
lidocaine than with other local anaesthetics in adults. The symptoms are mild to severe pain in the buttocks and legs that can last for days.
We also looked for longer-lasting sensory or motor disturbances caused by nerve damage by local anaesthetics, known as neurological
complications.
Background
Mild pain in the lower back is a common complaint following spinal anaesthesia (where a local anaesthetic is injected into the spinal
column rather than using general anaesthetic into the whole body). People may also experience headache and low blood pressure. TNS
symptoms are diDerent. They appear within a few hours up to 24 hours aHer spinal anaesthesia and may last up to two to five days.
Lidocaine (a local anaesthetic) continues to be used for spinal anaesthesia because of its unique short duration of action, intense blockade,
quick recovery, and suitability for day-case surgery, but alternatives are needed.
This review was originally published in 2005 and previously updated in 2009.
Study characteristics
We included all randomized trials and quasi-randomized trials comparing the frequency of TNS and neurological complications aHer
spinal anaesthesia with lidocaine compared to other local anaesthetic agents. Randomized trials compare two or more treatments where
the treatments are allocated to participants in a random manner that cannot be predicted by the study organizers. Quasi-randomized
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studies  are  similar but are not truly random, but carry  a greater likelihood that the study organizer can predict which treatment
the participants receive (e.g. based on date of birth or the order in which people were recruited).
The evidence is current to 25 November 2018.
Key results
We included 24 trials reporting on 2226 participants, 239 of whom developed TNS. There was no evidence TNS was associated with
any specific neurological disease and symptoms disappeared spontaneously by the fiHh postoperative day. The risk of developing
TNS with lidocaine for spinal anaesthesia was increased compared to bupivacaine, prilocaine, or procaine; and similar compared to 2-
chloroprocaine and mepivacaine.
Specifically, when alternative local anaesthetics were compared directly to lidocaine, the risk of developing TNS was reduced by between
82% and 90% when bupivacaine, levobupivacaine, prilocaine, procaine, and ropivacaine were used rather than lidocaine. There were no
clear diDerences in TNS between lidocaine and 2-chloroprocaine or mepivacaine. In the case of 2-chloroprocaine, TNS occurred in only one
study and the results varied greatly for the small number of participants. Painful symptoms stopped by the fiHh postoperative day in all
participants. Among pregnant women undergoing surgery, only 3/310 women developed TNS; no conclusions could be drawn on whether
symptoms were more likely with lidocaine.
The authors also used the statistical method of network meta-analysis to compare the various local anaesthetics. This analysis similarly
showed that the risk of TNS was lower for bupivacaine, levobupivacaine, prilocaine, procaine, and ropivacaine, while 2-chloroprocaine
and mepivacaine did not diDer in risk of TNS compared to lidocaine.
Quality of the evidence
Due to the very low- to moderate-quality of evidence among currently available studies, future research eDorts in this field are needed to
assess alternatives to lidocaine that can provide high-quality anaesthesia without TNS development.
Conclusion
Lidocaine has been the drug of choice for inducing spinal anaesthesia in ambulatory surgery (or day surgery) because of its rapid onset
of action, intense nerve blockade, and short duration of action. The present review shows that lidocaine is more likely to cause TNS than
bupivacaine, prilocaine, and procaine. However, these drugs produce longer local anaesthetic eDects and therefore are not desirable for
ambulatory patients.
Our results suggest that 2-chloroprocaine might be a viable alternative to lidocaine for day surgery of short duration and obstetric
procedures since this local anaesthetic has a rapid onset of action, is quickly metabolized, and has low toxicity. However, this conclusion
is based on only two studies and low-quality evidence.
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings for the main comparison.   Risk of transient neurological symptoms with spinal lidocaine compared to other local anaesthetic in
adults undergoing surgery
Risk of transient neurological symptoms (TNS) with spinal lidocaine compared to other local anaesthetics in adults undergoing surgerya
Patient or population: adult undergoing surgery
Settings: hospital or ambulatory surgery setting (Belgium, Brazil, Canada, Denmark, Egypt, Finland, Iran, Italy, Lebanon, Nepal, the Netherlands, Norway, Spain, Switzer-
land, Turkey, USA)
Intervention: spinal lidocaine
Comparison: other local anaesthetics as indicated
Anticipated absolute effectsb (95% CI)Outcomes
Risk with li-
docaine











Presence of any TNS –lidocaine vs
bupivacaine
Follow-up: range 1–30 days
210 per 1000
 
176 fewer per 1000 (191










reduced the risk of TNS
compared to lidocaine.
Presence of any TNS – lidocaine vs 2-
chloroprocaine
Follow-up: range 1–7 days
106 per 1000
 
97 fewer per 1000 (105 few-











have resulted in no dif-
ference in the risk of TNS
compared to lidocaine.
Presence of any TNS – lidocaine vs lev-
obupivacaine
Follow-up: range 2–7 days
183 per 1000
 
159 fewer per 1000 (180











have reduced the risk of
TNS compared to lido-
caine.
 
Presence of any TNS – lidocaine vs
mepivacaine
Follow-up: range 1–5 days





274 (4 RCTs) ⊕⊝⊝⊝
Very lowd,e,f
Mepivacaine may have re-
sulted in no difference in
the risk of TNS compared
to lidocaine but the evi-



























































































































































































Presence of any TNS – lidocaine vs
prilocaine
Follow-up: range 1–5 days
127 per 1000
 
104 fewer per 1000 (118










duced the risk of TNS
compared to lidocaine.
Presence of any TNS – lidocaine vs
procaine
Follow-up: range 2–3 days
292 per 1000
 
251 fewer per 1000 (281











duced the risk of TNS
compared to lidocaine.
 
Presence of any TNS – lidocaine vs
ropivacaine
Follow-up: range 2–7 days
200 per 1000
 
180 fewer per 1000 (198











reduced the risk of TNS
compared to lidocaine.
CI: confidence interval; TNS: transient neurological symptoms; RCT: randomized controlled trial; RR: risk ratio.
GRADE Working Group grades of evidence
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
a'Summary of findings' table is based on pair-wise meta-analysis (Figure 1). Results of the network meta-analysis are presented in Table 2; Table 3; Table 4 and Figure 2; Figure
3; Figure 4; Figure 5; Figure 6; Figure 7.
bThe risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative e:ect of the intervention (and
its 95% CI).
cDowngraded one level due to limitations in the design and implementation.
dDowngraded one level due to high probability of publication bias.
eDowngraded one level due to imprecision of results.




















































































































































































































































































































































































































































































































































































Figure 2.   Network meta-analysis plot of interactions among included studies displayed for a random-e:ects, risk ratio model, regarding the risk of
transient neurological symptoms following spinal anaesthesia with lidocaine versus other local anaesthetics in adults undergoing surgery. Each node
represents an individual local anaesthetic. The node size is proportional to the number of studies.
The node colours are determined by the individual study 'Risk of bias' assessment (green: no concerns; yellow: some concerns; red: major concerns).
The width of the edges is proportional to the inverse variance of the e:ect size. The edge colours reflect the average risk of bias. bupi: bupivacaine;




























































































































































































Figure 3.   Risk of bias (RoB) assessment among studies included in the network meta-analysis with direct e:ect estimation is displayed, regarding
the risk of transient neurological symptoms following spinal anaesthesia with lidocaine versus other local anaesthetics in adults undergoing surgery.
Direct RoB was determined by the average RoB assigned to each particular network interaction. bupi: bupivacaine; chloro: 2-chloroprocaine; levo:





























































































































































































Figure 4.   Contributions of indirect and mixed e:ects in the network meta-analysis, regarding the risk of transient neurological symptoms following
spinal anaesthesia with lidocaine versus other local anaesthetics in adults undergoing surgery. bupi: bupivacaine; chloro: 2-chloroprocaine; levo:





























































































































































































Figure 5.   Analysis of imprecision among studies included in the network meta-analysis, regarding the risk of transient neurological symptoms
following spinal anaesthesia with lidocaine versus other local anaesthetics in adults undergoing surgery. bupi: bupivacaine; chloro: 2-





























































































































































































Figure 6.   Heterogeneity assessment in network meta-analysis displaying confidence and prediction intervals, regarding the risk of transient
neurological symptoms following spinal anaesthesia with lidocaine versus other local anaesthetics in adults undergoing surgery. bupi: bupivacaine;





























































































































































































Figure 7.   Summary of risk of bias assigned to studies included in the network meta-analysis across six domains: study limitations, imprecision,
heterogeneity, incoherence, indirectness, publication bias, regarding the risk of transient neurological symptoms following spinal anaesthesia with
lidocaine versus other local anaesthetics in adults undergoing surgery. Output was created with CINeMA soKware. bupi: bupivacaine; chloro: 2-
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B A C K G R O U N D
Description of the condition
August Bier performed the first spinal anaesthesia in 1898
using cocaine, which was the first known local anaesthetic (Bier
1899). Cocaine was soon replaced by another less toxic local
anaesthetic, amylocaine. Other local anaesthetics were gradually
introduced: procaine, 2-chloroprocaine, dibucaine, lidocaine,
tetracaine, mepivacaine, prilocaine, bupivacaine, and finally
ropivacaine and levobupivacaine. Lidocaine, procaine, tetracaine,
mepivacaine, dibucaine, and bupivacaine are still used for spinal
anaesthesia (Axelrod 1998; Hiller 1997; Holmdahl 1998; Iselin-
Chaves 1996; Masuda 1998; Tagariello 1998). Spinal anaesthesia
allows patients to avoid the undesirable eDects of general
anaesthetic drugs (Doleman 2018; Miller 2018), and may reduce
the likelihood  of patients having long-term pain aHer surgery
(Weinstein 2018). However, spinal anaesthesia does have problems,
including postdural puncture headache (Aravelo-Rodriguez 2017).
The increase in day-case surgery has generated a need for a local
anaesthetic with a quick onset and short duration of action that
allows for a speedy recovery and early discharge. So far, this profile
is fulfilled only by lidocaine (Liu 1998).
Intrathecally (spinally) administered local anaesthetics cause
reversible blockade of nerve impulse conduction in the aDected
nerve roots. Experiments on animals have shown that all tested
local anaesthetics have potentially neurotoxic eDects that are
dependent on the dosage used and the duration of exposure (Li
1985). All local anaesthetics can cause permanent nerve damage
when administered in a high concentration or when applied over a
long period of time.
However, retrospective and prospective surveys and databases
dealing with postoperative outcomes have shown that serious and
permanent neurological complications aHer spinal anaesthesia
are rare events (Corbey 1998; Dahlgren 1995; Freedman 1998;
Noble 1971; Phillips 1969; Renck 1995; Tarkkila 1991; Vandam
1955). Reported cases of such permanent neurological deficits
involve all known local anaesthetics (Auroy 1997; Green 1961;
Kane 1981; Sumi 1996; Vandam 1960). 2-Chloroprocaine is an
example of a local anaesthetic that has been used for spinal
anaesthesia since 1952 (Foldes 1952), especially for obstetric
epidural anaesthesia because of its rapid onset of action, quick
metabolism, and low toxicity (Winnie 2001). In the early 1980s
reports about permanent neurological deficits in eight people who
inadvertently received high doses of 2-chloroprocaine intrathecally
were published (Moore 1982; Reisner 1980). Although these
sequelae were probably due to the combination of low pH and the
presence of the antioxidant bisulfite, the use of 2-chloroprocaine
was then abandoned.
From the beginning of 1990, a number of cases were published
reporting cauda equina syndrome that was related to the
introduction of a microcatheter technique for continuous spinal
anaesthesia with hyperbaric 5% lidocaine (the drug of choice)
(Rigler 1991; Schell 1991).
In 1993, a new adverse eDect, transient neurological toxicity,
was described in people recovering from single injection spinal
anaesthesia with lidocaine (Schneider 1993). In the following years,
new names for this condition appeared in the literature including
transient radicular irritation (TRI) (Hampl 1995a) and transient
neurological symptoms (TNS) (Hampl 1998).
The symptoms of TNS can appear in a few hours or within up to 24
hours; that is, well aHer full recovery (return of sensory and motor
function) has been made from uneventful spinal anaesthesia.
These symptoms consist of pain originating in the gluteal region
and radiating to both lower extremities, in the absence of abnormal
neurological examination or imaging (Gerancher 1997; Pollock
2000; Tarkkila 1995).
Lower back pain is diDerent from pain experienced in the buttocks
and lower extremities aHer recovery from spinal anaesthesia, which
has been characterized as 'transient neurological symptoms';
this also shows no evidence of localized nerve damage. Studies
with diDerent concentrations and doses of lidocaine have shown
that the risk of TNS was not dose- or concentration-dependent
(Freedman 1998; Hampl 1996; Pollock 1999; Tong 2003). All forms of
lidocaine have been associated with TNS: hyperbaric (Tong 2003);
isobaric (Hampl 1996); and when diluted with cerebrospinal fluid
(Pollock 1999). The cause of this painful condition is still unknown
and none of the speculations on its origin have been substantiated.
The term 'transient neurological symptoms' implies neurological
pathology. Failing identification of the pathogenesis of TNS, there
should be consideration given to choosing a neutral descriptive
term which does not imply particular causation.
Description of the intervention
Spinal anaesthesia consists of using a fine needle to locate the
fluid-filled subarachnoid space around the spinal cord and to
inject local anaesthetics before surgery. In some circumstances,
spinal anaesthesia is a valuable alternative to general anaesthesia.
For short procedures and procedures conducted in ambulatory
settings, a rapid, short-acting anaesthesia may be beneficial. The
chosen medication and dose can aDect the quality, duration and
potential adverse eDects of spinal anaesthesia. Consequently, all
these factors are important when choosing a specific technique.
Lidocaine is an eDective agent for inducing spinal anaesthesia but
also known to be associated with TNS. There are many alternative
agents that may be associated with a lower incidence of this
adverse event.
How the intervention might work
TNS has been interpreted as a sign of possible neurotoxicity of local
anaesthetics (Casati 1998; Douglas 1995; Hiller 1997; Lynch 1997).
However, as the pathogenesis of TNS remains unknown, potential
explanations as to why lidocaine may be associated with a higher
incidence of TNS than other local anaesthetics remain speculative.
Why it is important to do this review
Previous versions of this review have suggested that lidocaine is
more likely to cause TNS than many alternative agents. In this
update, we sought further data published since 2009 to confirm
or modify our previous findings. We also added a network meta-
analysis (NMA), which allows us to perform direct and indirect
comparisons between all types of interventions, which may help
clarify which specific local anaesthetics present the lower risk of
TNS, by ranking these in terms of risk of TNS.
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
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O B J E C T I V E S
To determine the frequency of TNS aHer spinal anaesthesia with
lidocaine and compare it with other types of local anaesthetics
by performing a meta-analysis for all pair-wise comparisons, and
conducting network meta-analysis (NMA) to rank interventions.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered randomized controlled trials (RCTs), and quasi-
RCTs (i.e. in which participants were allocated to treatment or
control groups in a non-random way such as alternate allocation,
allocation by day of the week, odd-even study numbers), that were
published in full, regardless of blinding.
The included studies could have included any type of surgery, any
spinal needle size, and any patient positioning aHer administration
of the intrathecal local anaesthetics.
Types of participants
We included all adults who received spinal anaesthesia. The follow-
up of these participants was at least 24 hours and longer for
participants who developed TNS. We chose this time interval
because the symptoms of TNS appear within 24 hours aHer spinal
anaesthesia (Aouad 2001).
Types of interventions
The included studies had to have two or more arms that used a
distinct local anaesthetic (irrespective of the dose, concentration,
and baricity of the solution) for spinal anaesthesia in preparation
for surgery.
We excluded studies dealing with meperidine as a sole intrathecal
agent, or combinations of local anaesthetics and opioids. We
also excluded studies in which spinal anaesthesia was combined
with epidural analgesia to restrict our analysis to intrathecal
injection of pure local anaesthetics. This approach was meant to
support  the clinical and methodological comparability across all
direct comparisons in the whole network.
Types of outcome measures
Primary outcomes
• Presence of any transient neurological symptoms (TNS), defined
as pain originating in the gluteal region and radiating to both
lower extremities and appearing within up to 24 hours aHer full
recovery (return of sensory and motor function) has been made
from uneventful and non-complicated spinal anaesthesia.
Secondary outcomes
• Postoperative neurological symptoms (sensory deficits
including numbness and weakness) which lasted longer than 24
hours aHer onset of spinal anaesthesia and which did not exist
before the anaesthetic.
• Postoperative neurological signs (motor deficits including
weakness in a radicular distribution) which lasted longer than 24
hours aHer onset of spinal anaesthesia and which did not exist
before the anaesthetic.
Search methods for identification of studies
Electronic searches
We searched for studies with systematic and sensitive search
strategies as outlined in Chapter 6.4 of the Cochrane Handbook of
Systematic Reviews of Interventions (Higgins 2011). We applied no
restrictions to language or publication status.
We searched the following databases:
• Cochrane Central Register of Controlled Trials Register
(CENTRAL; the Cochrane Library, 2018, Issue 9);
• MEDLINE ALL, OvidSP (1966 to 25 November 2018);
• Elsevier Embase (1980 to 25 November 2018);
• LILACS (25 November 2018).
We developed a subject-specific search strategy in MEDLINE and
modified it appropriately for the other databases. This search
strategy allowed retrieval of trials of any two local anaesthetics for
spinal anaesthesia. Where appropriate, we used the search strategy
recommended in the Cochrane Handbook for Systematic Reviews of
Interventions for identifying RCTs (Lefebvre 2011). See Appendix 1;
Appendix 2; Appendix 3; Appendix 4 for the search strategies.
Searching other resources
We searched ClinicalTrials.gov Registry of Clinical Trials by National
Institutes of Health (NIH) and the World Health Organization
International Clinical Trials Registry Platform (www.who.int/ictrp/
en/) on 25 November 2018.
We scanned the reference lists and citations of relevant studies
and reviews for further references to trials. When necessary, we
contacted trial authors for additional information.
Data collection and analysis
Selection of studies
Four review authors (PF, EMT, NLP, and JAB) assessed the search
results, and excluded irrelevant reports. They independently
examined studies for eligibility without blinding of study authors,
institutions, journal of publication, and results. We retrieved
and read the full text of potentially relevant studies and
decided which studies to include. We listed excluded studies
in the Characteristics of excluded studies table. We resolved
disagreements by discussion.
Data extraction and management
Four review authors (PF, EMT, NLP, and JAB) recorded and
documented the following information from the included studies in
the Characteristics of included studies table: experimental design
characteristics; number of participants; demographics; country of
investigation; treatment groups; concentration and volume of the
local anaesthetic used; duration of the follow-up period; and spinal
needle size and shape. We regarded TNS, sensory deficits, or motor
deficits as three separate outcomes.
We independently extracted data using a standard form and agreed
on the data before entry into Review Manager 5 (Review Manager
2014). We resolved any discrepancies by discussion and internal
correspondence. The data collection form very closely resembled
the form used in the previous versions, already assessed for
usability.
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)









Cochrane Database of Systematic Reviews
Assessment of risk of bias in included studies
Four review authors (PF, EMT, NLP, and JAB) independently
and without blinding assessed the risk of bias. We resolved
disagreements by discussion and internal correspondence.
We assessed the risk of bias for the domains: random sequence
generation, allocation concealment, blinding of participants,
blinding of personnel, blinding of assessors, incomplete outcome
data, and selective reporting. Study level judgements are presented
in the 'Risk of bias' table of the Characteristics of included studies
table (Appendix 6), and were made as described in the Cochrane
Handbook for Systematic Reviews of Interventions, Section 8.5
(Higgins 2011).
We summarized the overall risk of bias for each study depending on
the judgements for the domains:
• low risk of bias: low risk of bias for all key domains;
• unclear risk of bias: unclear risk of bias for one or more key
domains;
• high risk of bias: high risk bias for one or more key domains.
Measures of treatment e:ect
We used the risk ratio (RR) as the eDect estimate. We estimated the
pair-wise relative treatment eDects of the competing interventions
in each included study using the RR with 95% confidence intervals
(95% CI).
Unit of analysis issues
We included multi-arm studies in the data set as a series of two-arm
comparisons. In the pair-wise direct comparison meta-analyses, no
overall summary statistic was estimated across all interventions. In
the NMA, the standard error of each two-arm comparison within a
multi-arm study was adjusted by a method proposed by Rücker and
Schwarzer (Rücker 2012; Rücker 2014), that uses back-calculated
standard errors in the weighted least squares estimator to reflect
the within-study correlation.
We did not find nor include cluster randomized trials. As each
participant received a single surgical procedure, there were no trials
with a crossover design.
Dealing with missing data
For the trials where dropouts were reported but without mention
of their outcomes, we contacted the authors and included the
missing data, where possible, to reduce the number of excluded
participants.
Assessment of heterogeneity
Clinical and methodological diversity always occur  between
diDerent studies, making heterogeneity inevitable (Higgins 2011).
We performed meta-analysis only in the case of low- to moderate-
clinical heterogeneity, defined as similar positioning for the
procedure (lithotomy versus supine), and shape and size of the
spinal needle. This heterogeneity or diversity reflects diDerences
in potential eDect modifiers such as patient mix or agent dose. We
assessed statistical heterogeneity as outlined below.
Measures and tests for pair-wise meta-analysis heterogeneity
We assessed statistical heterogeneity by the Q test, the I2 statistic,
and a comparison of the between-trial variance (tau2) of the eDect
estimates for each pair-wise comparison. We used a Chi2 test to
examine the Q statistic for evidence of heterogeneity. The I2 statistic
was interpreted following the guidelines suggested by Higgins
2011:
• 0% to 40% might not be important;
• 30% to 60% may represent moderate heterogeneity;
• 50% to 90% may represent substantial heterogeneity;
• 75% to 100% represents considerable heterogeneity.
Assessment of statistical inconsistency
Inconsistency is the statistical manifestation of intransitivity and
occurs when the direct and indirect estimates in a network of
treatments do not agree. This is analogous to the distinction
between clinical/methodological heterogeneity and statistical
heterogeneity in the pair-wise meta-analysis (Cipriani 2013).
Consistency within, and between, designs were assessed by
decomposition of Cochran's Q statistic. The consistency of
direct and indirect treatment comparisons used back-calculation
methods (Dias 2010), as implemented in the netsplit function. If
necessary, we examined net heat plots (Krahn 2013).
Assessment of transitivity across treatment comparisons
The main assumption underlying indirect and mixed comparison is
that there are no important diDerences between trials comparing
diDerent local anaesthetics other than the agents given. As an
example, consider the comparison of three agents A, B, and C
with the eDect sizes labelled AB, AC, and BC in studies reporting A
versus C and B versus C. Under the assumption of transitivity, then
ABindirect = ACdirect – BCdirect.
We assessed the assumption of transitivity by comparing the
distribution of potential eDect modifiers across the diDerent pair-
wise comparisons. Variation in the spinal dose of local anaesthetic
among studies was considered acceptable for combining. We also
considered varied surgical procedures and varied populations as
suitable for combining.
We assumed that participants who fulfilled the inclusion criteria
and received these interventions would have been equally eligible
to be randomized to any local anaesthetic in a hypothetical joint
RCT of all local anaesthetics (Chaimani 2017). We assumed that
this met the requirement of transitivity for an NMA (Caldwell 2005;
Salanti 2012).
Assessment of reporting biases
Reporting bias occurs when the dissemination of research findings
is influenced by the nature and direction of results. We constructed
and examined funnel plots for asymmetry to detect reporting
biases. We performed statistical tests of funnel plot asymmetry as
necessary.
Data synthesis
We followed guidance on NMA in the PRISMA extension (Hutton
2015), and documents developed by the Cochrane Comparing
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Multiple Interventions Methods Group (methods.cochrane.org/
cmi/about-us).
Methods for direct treatment comparisons
We conducted  pair-wise meta-analyses  for all comparisons of
local anaesthetics. We assumed a random-eDects model for
all data syntheses. We used an inverse variance weighting for
summary statistics and random-eDects models as we expected
methodological and clinical heterogeneity across the included
studies resulting in varying eDect sizes between studies of pair-wise
comparisons. We reported summary statistics as point estimates
with 95% CIs; and determined summary statistics to indicate
a diDerence if 95% CIs did not cross the line of identity. We used
Review Manager 5, for data synthesis, statistical analysis, and
creation of forest plots (Review Manager 2014).
Methods for indirect and mixed comparisons
We performed a random-eDects NMA for the primary outcome
of TNS using all included studies based on a graph theoretical
approach (Rücker 2012), within a frequentist framework in the R
statistical platform (R 2018), using the package netmeta (Rücker
2016). Spinal anaesthesia with lidocaine was the reference group
due to its known association with TNS (see:  Description of the
intervention). The geometry of the network was displayed using
graph theory as implemented in the netgraph function of netmeta.
For display of specific treatments in the NMA, abbreviations
were used: bupi: bupivacaine; chloro: 2-chloroprocaine; levo:
levobupivacaine; lido: lidocaine; mepi: mepivacaine; prilo:
prilocaine; pro: procaine, and ropi: ropivacaine. Nodes in the
network structure represented individual local anaesthetics.
Relative treatment ranking
For the primary outcome of TNS, we ranked the competing
treatments by P scores using the netrank function in netmeta. P
scores allow ranking of treatments on a continuous 0 (worst) to
1 (better) scale and are derived from the P values of all pair-wise
comparisons. P scores are a frequentist analogue and numerically
similar to the Bayesian Surface Under the Cumulative Ranking
curve (SUCRA) values (Rücker 2015). The P score of treatment is the
mean certainty that it is better than another treatment.
Subgroup analysis and investigation of heterogeneity
We were unable to perform the preplanned subgroup analyses
included participant positioning (lithotomy versus supine), the
shape and size of the spinal needle, and pregnancy because of the
available amount of data.
Sensitivity analysis
We performed no sensitivity analyses. Regarding the missing data,
assuming that these data were missing at random, we intended to
analyze only the available data (i.e. ignoring the missing data); and
to evaluate how sensitive results were to reasonable changes in the
assumptions that were made.
'Summary of findings' table and GRADE
Methods for evaluating the quality of evidence of a NMA have
been proposed by Puhan and colleagues (Puhan 2014), and Salanti
and colleagues (Salanti 2014). The quality of the body of evidence
is assessed by the domains of study limitations, indirectness,
inconsistency (heterogeneity, incoherence), imprecision, and risk
of publication bias.
For the evaluation of the quality of evidence derived from NMA,
we used a web app online tool denoted Confidence in Network
Meta-Analysis (version 0.6) (CINeMA 2018; CINeMA). It implements
proposals by Salanti 2014 and uses the netmeta 2013 package
for calculations. According to the GRADE for NMA guidelines, we
assessed the risk of bias for each treatment comparison separately.
R E S U L T S
Description of studies
Results of the search
The results of the search are outlined in Figure 8.
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Figure 8.   Study selection flow diagram corresponding to the last search update, up to November 2018.
 
The electronic database searches yielded 2002 citations. No
additional records were found through other sources. AHer we
removed duplicates, 1264 unique citations remained. We excluded
1185 citations on the basis of title and abstract.
We considered 76 full-text studies dealing with neurological
complications and spinal anaesthesia with lidocaine. Of these, we
excluded 52 studies for the reasons cited in the Characteristics
of excluded studies table. There are two studies awaiting
classification (see Characteristics of studies awaiting classification
table), and one ongoing study (see Characteristics of ongoing
studies table).
Included studies
See Characteristics of included studies table.
Interventions
We included 24 RCTs in the final analysis and respective NMA. The
characteristics of these studies can be found in Table 1. One RCT
was identified in the first review update (Casati 2007). Eight were
identified in the current update (Ali Hassan 2015; Etezadi 2013;
Pradhan 2010; Teunkens 2016; de Santiago 2010; Imbelloni 2008a;
Imbelloni 2008b; Yazicioglu 2013). Twenty-one studies satisfied the
inclusion criterion of comparing lidocaine as one treatment arm
with diDerent local anaesthetics in the second treatment arm. The
local anaesthetic in this second arm consisted of bupivacaine in 12
studies (Ali Hassan 2015; Aouad 2001; Etezadi 2013; Hampl 1995a;
Hampl 1998; Keld 2000; Philip 2001; Pollock 1996; Pradhan 2010;
Salmela 1998; de Santiago 2010; Yazicioglu 2013); prilocaine in four
studies (de Weert 2000; Hampl 1998; Martinez-Bourio 1998; Salmela
1998); mepivacaine in three studies (Liguori 1998; Salazar 2001;
Salmela 1998); procaine in two studies (Hodgson 2000; Le Truong
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2001); ropivacaine and levobupivacaine in one study (Breebaart
2003), and 2-chloroprocaine in one study (Casati 2007). There were
five studies with more than two treatment arms (Breebaart 2003;
Hampl 1998; Pollock 1996; Salmela 1998; Teunkens 2016). Hampl
1998 used two concentrations of lidocaine and, as the outcome of
interest is not dependent on the concentration (Freedman 1998;
Hampl 1996; Pollock 1999; Tong 2003), we pooled the results of
the two groups. Four studies had three treatment groups: two
alternative local anaesthetics in addition to lidocaine (Breebaart
2003; Pollock 1996; Salmela 1998; Teunkens 2016). In one study, a
control group with participants receiving general anaesthesia was
not taken into consideration for statistical analysis (Hampl 1995a).
Countries and other di%erences between the studies
Four studies were conducted in the USA; three each in Scandinavia
and Spain; two each in Brazil, Switzerland, and Belgium; and
one each in Canada, Egypt, Iran, Italy, Lebanon, Nepal, the
Netherlands, and Turkey. Three studies diDered from the rest
because the participants were pregnant women (Aouad 2001; Philip
2001; Pradhan 2010). All studies investigated the frequency of
TNS; two reported no events in any of the studied arms (Aouad
2001; Teunkens 2016). Seven studies had no events in the 'other
treatment' arm (Breebaart 2003; Casati 2007; de Weert 2000; Hampl
1995a; Le Truong 2001; Liguori 1998; Pollock 1996). Six RCTs
included subgroups of participants exposed to lithotomy or the
supine position and pencil point or sharp spinal needles (Etezadi
2013; Le Truong 2001; Martinez-Bourio 1998; Pollock 1996; Salmela
1998; Østgaard 2000). In the remaining RCTs, most participants
underwent surgery in the supine position, and each study used only
one type of spinal needle (sharp or pencil point, 27 G or larger).
Outcomes
All included studies investigated the risk of TNS, and no study
was set up to investigate sensory and motor deficits aHer spinal
anaesthesia. The follow-up period was at least 24 hours, and all
participants with TNS were followed longer than 24 hours, until
recovery. The interviewer who assessed the occurrence of TNS was
blinded as to which treatment group the participant belonged to in
all but one RCT (de Weert 2000; in which blinding was unclear). In
nine of the studies the interview was done by telephone (Breebaart
2003; Casati 2007; Hodgson 2000; Keld 2000; Liguori 1998; Martinez-
Bourio 1998; Pollock 1996; Imbelloni 2008a; Imbelloni 2008b), and
in the remaining studies by direct contact with the participant,
except for Le Truong 2001 (where it was unclear).
Excluded studies
We excluded 52 studies aHer full-text review. The reasons for
exclusion included: a combination of local anaesthetics with other
medications; no relevant comparison; and absence of lidocaine in
any compared group or presence of lidocaine in all the groups.
Additional details are provided for 31 of these 52 studies. See
Characteristics of excluded studies table for further details.
Studies awaiting classification
There are two studies awaiting classification (Frisch 2018; Gozdemir
2016); see: Characteristics of studies awaiting classification table.
Ongoing studies
We identified one ongoing study (NCT02818894); see:
Characteristics of ongoing studies table. This ongoing study will
compare lidocaine to bupivacaine spinal anaesthesia in people
having a total hip arthroplasty. The objective of this study is to
compare the eDect of two spinal anaesthesia treatments on TNS.
Risk of bias in included studies
See the 'Risk of bias' graph (Figure 9), 'Risk of bias' summary Figure
10, and 'Risk of bias' tables in the  Characteristics of included
studies table for more details.
 
Figure 9.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
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Figure 10.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
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Figure 10.   (Continued)
 
The overall quality of the included RCTs based on risk of bias
assessment ranged from unclear to high. All of the studies were
randomized; however, 10 studies did not specify the method of
randomization (referring to a random number table, computer-
generated random number sequence, tossing coin, etc.) and were
thus considered to have an unclear risk of bias with regard to
randomization of participants (Aouad 2001; de Weert 2000; Hampl
1995a; Keld 2000; Le Truong 2001; Pollock 1996; Pradhan 2010;
Salazar 2001; Salmela 1998; Østgaard 2000).
Allocation
None of the included studies showed high risk of bias. Five studies
specified adequate concealment of allocation (Hodgson 2000;
Martinez-Bourio 1998; Pradhan 2010; Teunkens 2016; Østgaard
2000). Nine authors described allocation concealment consisting
of participant assignment being determined by sealed envelopes
or coded envelopes (Aouad 2001; Casati 2007; de Weert 2000;
Etezadi 2013; Fanelli 2009; Gozdemir 2010; Imbelloni 2010; Pollock
1996; Salmela 1998). However, because these descriptions did not
specify "sequentially numbered, sealed, opaque envelopes," the
risk of bias was unclear. Ten studies did not describe allocation
concealment, presenting an unclear risk of bias (Ali Hassan 2015;
Breebaart 2003; Hampl 1995a; Hampl 1998; Keld 2000; Le Truong
2001; Liguori 1998; Pawlowski 2012; Philip 2001; Salazar 2001).
Blinding
Nine studies had a complete blinding procedure (participant,
provider, and assessor) (Breebaart 2003; Casati 2007; Gozdemir
2010; Hampl 1995a; Hampl 1998; Liguori 1998; Pawlowski 2012;
Philip 2001; Teunkens 2016). Six studies had blinding of participant
and assessor (Aouad 2001; Etezadi 2013; Hodgson 2000; Keld 2000;
Le Truong 2001; Pollock 1996). Blinding was unclear, inadequate, or
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not performed in eight trials (Ali Hassan 2015; de Weert 2000; Fanelli
2009; Martinez-Bourio 1998; Pradhan 2010; Salazar 2001; Østgaard
2000; Salmela 1996).
Incomplete outcome data
Three studies reported outcomes for dropouts (Martinez-Bourio
1998; Philip 2001; Pollock 1996). Six RCTs with dropouts failed
to report outcomes (de Weert 2000: one participant; Keld 2000:
one participant; Le Truong 2001: six participants; Liguori 1998:
three participants; Pawlowski 2012: seven participants; Teunkens
2016: seven participants). For two studies dropout information was
unclear (Pradhan 2010; Østgaard 2000); see the Characteristics of
included studies table for further details.
Selective reporting
Only one study stated whether all predefined or clinically relevant
and reasonably expected outcomes were recorded and fully
reported (Teunkens 2016). All of the other studies were reported in
such a way that there was unclear risk of bias concerning selective
reporting.
Other potential sources of bias
None noted.
E:ects of interventions
See: Summary of findings for the main comparison Risk of
transient neurological symptoms with spinal lidocaine compared
to other local anaesthetic in adults undergoing surgery
We included 24 studies with 2253 enrolled participants in the NMA
(Table 1; Table 2). Reported outcomes were available for 2226
participants. There were 27 (1.65%) dropouts, or missing or not
reported outcomes. Due to these numbers, we did not perform any
related sensitivity analysis.
In 13 RCTs, we found no events of TNS in the comparator treatment
group (Ali Hassan 2015; Aouad 2001; Breebaart 2003; Casati 2007;
de Weert 2000; Hampl 1995a; Le Truong 2001; Liguori 1998; Pollock
1996; Pradhan 2010; Teunkens 2016; de Santiago 2010; Yazicioglu
2013). In six of these 13 RCTs, there were no cases of TNS (Ali Hassan
2015; Aouad 2001; Pradhan 2010; Teunkens 2016; de Santiago 2010;
Yazicioglu 2013).
Pair-wise meta-analysis of lidocaine versus alternative local
anaesthetic agents
Rate of development of transient neurological symptoms
Figure 1 summarizes our findings for all pair-wise comparisons
between lidocaine and individual alternative agents. A summary RR
comparing all alternative local anaesthetic agents to lidocaine was
not estimated.
In total, 201/1097 (18%) participants who received lidocaine
developed TNS (occurrence of TNS by study is presented in Table 1).
The RR for the development of TNS was lower for bupivacaine
(RR 0.16, 95% CI 0.09 to 0.28; I2 = 5%; studies = 12, participants =
1220; moderate-quality evidence), levobupivacaine (RR 0.13, 95%
CI 0.02 to 0.69; I2 = 0%; studies = 2, participants = 120; low-quality
evidence), prilocaine (RR 0.18, 95% CI 0.07 to 0.49; I2 = 0%; studies
= 4, participants = 429; moderate-quality evidence), procaine (RR
0.14, 95% CI 0.04 to 0.52; I2 = 0%; studies = 2, participants = 130;
moderate-quality evidence), and ropivacaine (RR 0.10, 95% CI 0.01
to 0.78; I2 = 0%; studies = 2, participants = 90; low-quality evidence)
(Analysis 1.1).
The RR was not diDerent for 2-chloroprocaine (RR 0.09, 95% CI 0.01
to 1.51; I2 = 0%; studies = 2, participants = 94; low-quality evidence),
and mepivacaine (RR 1.01, 95% CI 0.18 to 5.82; I2 = 61%; studies = 4,
participants = 274; very low-quality evidence).
Postoperative neurological symptoms (sensory deficits
including numbness and weakness)
There were no reports of ongoing sensory changes for the duration
of follow-up in any of these trials.
Postoperative neurological signs (motor deficits including
weakness in a radicular distribution)
There were no reports of ongoing motor changes for the duration
of follow-up in any of these trials.
Network meta-analysis
See Table 3.
The NMA included 24 studies. These studies included eight diDerent
treatments. The total number of pair-wise comparisons was 32,
which included 11 unique comparisons. Compared to lidocaine, the
RR of TNS was lower for bupivacaine, levobupivacaine, prilocaine,
procaine, and ropivacaine. The RRs were in the range of 0.10 to 0.23
(Table 2). The RR for 2-chloroprocaine was also small (0.18), but
the 95% CIs were wide (0.02 to 1.53). The RR for mepivacaine was
greater than 1 suggesting an increased risk for TNS, but the 95% CIs
were wide (0.76 to 3.12). The tau2 was 0 and the I2 statistic was 0%;
this is consistent with no heterogeneity and no inconsistency. The
decomposition of Cochran's Q statistic revealed no heterogeneity
within or between designs. P values were greater than 0.3 (Table
4). The splitting of the contribution of direct and indirect evidence
did not demonstrate inconsistency; the 95% CI of the ratio of
ratios (direct versus indirect) crossed the line of identity for all
comparisons (Table 3).
A meta-analysis interaction plot for the 24 included studies showing
the geometry of network was generated by using CINeMA tool
(Figure 2).
Finally, we ranked the competing treatments by P scores, in terms
of risk of developing TNS aHer spinal anaesthesia. There was a clear
separation in the ranking of treatments (Table 5). The P scores of
lidocaine and mepivacaine were low and very low. The P scores of
the other treatments were 0.5 or above.
Subgroup analysis
We did not perform subgroup analysis based on participant
position (lithotomy versus supine) or the shape and size of the
spinal needle as we could not derive systematic data from the 24
included RCTs. Most participants were operated on in the supine
position and most used pencil-point needles (in most cases 25 G).
A subgroup analysis was not possible due to this lack of data.
A possible subgroup analysis concerned the eDect of pregnancy
on TNS. Three studies comparing bupivacaine versus lidocaine
(caesarean delivery: Aouad 2001; Pradhan 2010; postpartum tubal
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ligation: Philip 2001), had only three events (lidocaine one,
bupivacaine two) among the 310 participants. Considering the low
event rate, we did not perform subgroup analysis.
Missing data
Only one study stated clearly that all predefined or clinically
relevant and reasonably expected outcomes were recorded and
fully reported (Teunkens 2016). The other studies were reported
with an unclear risk of selective reporting, although none
mentioned any missing data. AHer contacting the authors, we were
leH with 27 (1.65%) dropouts.
Sensitivity analysis
An intention-to-treat analysis was possible for 14/20 studies.
Because of the small number of missing outcomes, we did not
attempt to impute optimistic and pessimistic missing outcomes for
the other five studies in a sensitivity analysis.
Summary of findings and GRADE
The CINeMA web app created a series of tables and plots for the
quality of evidence of an NMA. Study limitations were determined
by the average risk of bias aHer each investigator independently
assigned their assessment of direct risk of bias (Figure 3). The NMA-
generated risk of bias assessment for indirect and mixed-eDects
included in the interaction analysis is available in Figure 4. A large
proportion of studied interactions showed some or major concern
in terms of study limitations.
To assess imprecision, an RR outside of the range of 0.909 to
1.1 was considered clinically important. Each component table
within Figure 5 shows the imprecision judgement for each pair-wise
comparison. In the 28 pair-wise comparisons with either mixed or
indirect evidence, there were major concerns for imprecision in 18.
Among included studies in the NMA, there were no concerns
across studies in terms of heterogeneity (Figure 6), or incoherence
(Chi2 = 3.599, degrees of freedom = 8, P = 0.891). All studies
were considered to directly report TNS and thus indirectness was
assigned a judgement of low concern. Similarly, publication bias
was rated of low concern.
An aggregated chart summarizing all studies included in the NMA
across the domains is available in Figure 7. For example, the mixed
evidence for bupivacaine versus lidocaine has some concerns for
study limitations, but no concerns for another domain.
D I S C U S S I O N
Summary of main results
The main clinical question addressed by this review is whether local
anaesthetics used for spinal anaesthesia caused symptoms of TNS
less frequently than lidocaine.
We included 24 trials of mostly low- to moderate-quality evidence
(GRADE), reporting on 2226 participants of whom 239 developed
TNS, in the analysis. Included studies mostly had unclear to high
risk of bias. Compared with lidocaine, most local anaesthetics
were associated with a reduced risk of TNS development (with the
exception of 2-chloroprocaine and mepivacaine) (bupivacaine: RR
0.16, 95% CI 0.09 to 0.28; 12 studies; moderate-quality evidence; 2-
chloroprocaine: RR 0.09, 95% CI 0.01 to 1.51; 2 studies; low-quality
evidence; levobupivacaine: RR 0.13, 95% CI 0.02 to 0.69; 2 studies;
low-quality evidence; mepivacaine: RR 1.01, 95% CI 0.18 to 5.82;
4 studies; very low-quality evidence; prilocaine: RR 0.18, 95% CI
0.07 to 0.49; 4 studies; moderate-quality evidence; procaine: RR
0.14, 95% CI 0.04 to 0.52; 2 studies; moderate-quality evidence;
ropivacaine: RR 0.10, 95% CI 0.01 to 0.78; 2 studies; low-quality
evidence).
These data, with additional explanations, are found in the
Summary of findings for the main comparison. Approximately one
in five participants who received spinal anaesthesia with lidocaine
developed TNS.
The NMA included 24 studies. These studies assessed eight diDerent
local anaesthetics. The number of pair-wise comparisons was
32 and the number of unique  pair-wise comparisons was 11.
This analysis showed that, compared to lidocaine, the RRs of
TNS development were lower for bupivacaine, levobupivacaine,
prilocaine, procaine, and ropivacaine with RRs in the range of 0.10
to 0.23 while 2-chloroprocaine and mepivacaine did not diDer.
While Summary of findings for the main comparison for this review
focused on the pair-wise meta-analysis results, results from the
NMA can be found in  Table 2 (results of NMA),  Table 3,  Table 4,
and Table 5  (treatment ranking), as well as in  Figure 2  (network
structure),  Figure 3  (risk of bias assessments),  Figure 4,  Figure
5,  Figure 6, and  Figure 7. Updates of this review will consider
contemporary practices for presenting a 'Summary of findings'
table for NMA results.
Overall completeness and applicability of evidence
How much does TNS influence patients' level of satisfaction and
their rehabilitation? In one multicentre RCT, 20% of 453 participants
who received spinal anaesthesia with lidocaine for short urological
procedures developed TNS (Tong 2003). People with TNS had
higher pain scores, used more analgesics postoperatively, and
experienced higher degrees of functional impairment during the
two postoperative days than those who did not develop TNS.
Satisfaction was higher among people without TNS (96%) than in
people with TNS (89%). However, the proportion of participants
who stated they would accept future spinal anaesthesia was the
same (95%). It seems that the transitory pain and functional
impairment are not of such degree that they have a negative
influence on the patients' decisions to receive spinal anaesthesia
in the future. In contrast, in one epidemiological study of 1863
participants, 30% of the 104 participants who developed TNS aHer
intrathecal lidocaine rated their pain as severe (Freedman 1998).
Quality of the evidence
The present review showed that bupivacaine, prilocaine, and
procaine are less likely to cause TNSs than lidocaine, but the quality
of evidence was low to moderate based on GRADE assessments.
The quality of evidence comparing the risk of TNS following
bupivacaine spinal anaesthesia compared with lidocaine was
moderate, due to multiple studies in which blinding was
inadequate and two studies that reported eight participants lost
to follow-up (Ali Hassan 2015; Aouad 2001; Etezadi 2013; Keld
2000; Pollock 1996; Pradhan 2010; Salmela 1998; Teunkens 2016).
Low-quality of evidence supported levobupivacaine as causing less
TNS than lidocaine; the quality of evidence was downgraded for
relatively small sample sizes, a rare event of interest, and wide CIs
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(Breebaart 2003; Gozdemir 2010). Moderate-quality evidence also
supported prilocaine when compared with lidocaine; in this case,
the quality of evidence was decreased for concerns about blinding,
participants lost to follow-up, and pervasive unclear risk of bias.
The quality of evidence comparing 2-chloroprocaine, procaine, and
ropivacaine with lidocaine was low. In the case of 2-chloroprocaine,
only one study noted the event of interest (TNS), limiting the
quality with small sample size and imprecision (Casati 2007;
Teunkens 2016). The studies comparing procaine and ropivacaine
with lidocaine were limited by relatively small sample sizes, a
rare event of interest, wide CIs, and inadequate blinding, as well
as participants lost to follow-up (Breebaart 2003; Fanelli 2009;
Hodgson 2000; Le Truong 2001).
The quality of evidence comparing mepivacaine with lidocaine
presents an interesting problem. These studies had similar
limitations in terms of inadequate blinding, participants lost to
follow-up, and wide CIs (Liguori 1998; Pawlowski 2012; Salazar
2001; Salmela 1998). Furthermore, the studies demonstrated
a small overlap in CIs and diDerent directions of eDect, with
the CI including the null hypothesis. These data may represent
heterogeneity or no diDerence in eDect. See Summary of findings
for the main comparison for further details.
Potential biases in the review process
The consistent magnitude of the risk ratio reduction observed
when local anaesthetics such as bupivacaine, levobupivacaine,
prilocaine, procaine, and ropivacaine are used, compared to
lidocaine, is a strength of the present review.
However, the limitations were numerous. The events were so rare
that no randomized trial relating to this complication has been
performed. In the patient population contained in this review, the
total number of participants was only 2226. Only 239 developed
TNS and no prolonged neurological sequelae were reported. Within
the review, 13 of the included RCTs found no events of TNS in
the treatment comparator arm, and six of these studies found no
cases of TNS in either treatment arm.  No specific corrections were
made for studies with no events in either arm or for studies with
no events in one or more arm, which may have introduced bias in
the estimation of the treatment eDect. The lack of responsiveness
of many primary study authors to requests for information must be
taken into account. These rare events can be found in the literature
as case reports, retrospective and prospective surveys, or as reports
from databases for registration of postoperative complications.
Nevertheless, as the chosen primary outcome definitions were
dichotomous (presence or absence of the complications), no study
was excluded depending on alternative outcome definitions or
clinical heterogeneity (or both), prioritization of data from multiple
time points, the definition of subgroups, use of adjusted as
opposed to unadjusted data, or outcome surrogacy.
Consequently, we did not detect any marginal decisions around the
inclusion or exclusion of studies or use and analysis of data which
could have impacted on the findings of the review.
There were no relevant departures from the protocol (Zaric 2003)
(or last published version of the review, Zaric 2009) as a potential
source of bias (see DiDerences between protocol and review).
Finally, we attempted to conduct a comprehensive search for
studies, but the fact that two studies have not yet been
incorporated (see Characteristics of studies awaiting classification)
may be a source of potential bias. The results of these studies may
impact the conclusions of this review in the future.
Agreements and disagreements with other studies or
reviews
There have been no previous published systematic reviews
including short-acting local anaesthetics (such as prilocaine or
2-chloroprocaine), rendering conclusions of other reports mostly
speculative regarding the implications of these agents in the
development of TNS.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
There is low to moderate-quality evidence that transient
neurological symptoms (TNS) are probably less frequent following
spinal anaesthesia with bupivacaine, levobupivacaine, prilocaine,
procaine, and ropivacaine  than with lidocaine. Very-low to low-
quality evidence suggests that TNS occurs aHer 2-chloroprocaine
and mepivacaine is used for spinal anaesthesia at a similar
frequency with lidocaine, but the evidence is very uncertain.
Among the studies included in this review, approximately one in
five participants who received spinal anaesthesia with lidocaine
developed TNS. This review showed that painful symptoms that
are attributed to TNS ceased by the fiHh postoperative day in all
participants.
Finally, the risks of TNS should be weighed against the benefit of
rapid, short-acting anaesthesia and the patient's viewpoint must
be considered in the decision as to whether to use lidocaine for
ambulatory anaesthesia.
Globally, the quality of evidence of reported studies is of very
low to moderate quality and this should be taken into account
when interpreting the results of this review. Finally, the results of
one ongoing study (Characteristics of ongoing studies) and two
studies in the Studies awaiting classification section may alter the
conclusions of the review once assessed.
Implications for research
More data are necessary to accurately estimate the frequency
of TNS following the use of mepivacaine and 2-chloroprocaine.
2-Chloroprocaine, in particular, may be a suitable replacement
for lidocaine for spinal anaesthesia in ambulatory settings and
high-quality, appropriately powered and blinded randomized
controlled trials (RCT) are required to confirm these initial findings.
Similarly, high-quality RCTs enrolling pregnant women are needed
to generate conclusions about the frequency of TNS aHer spinal
anaesthesia in this specific patient population.
We acknowledge such definitive RCTs may be diDicult to perform
regarding the risk of TNS for diDerent local anaesthetic agents, and
some useful comparisons may be made using alternative designs
such as large prospective registries. A standardized definition of
outcomes is of prime importance. A registry may be the best
way to document the true risks of uncommon serious adverse
events of local anaesthetic agents, such as permanent neurological
deficits aHer regional anaesthesia. An international database for
registration of such rare events could be the solution to this
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)
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problem. Regional anaesthesia societies such as the European
Society of Regional Anaesthesia and Pain Therapy (ESRA), the
American Society of Regional Anesthesia (ASRA), and the Latin
American Society of Regional Anaesthesia (LASRA) might be
appropriate agents.
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ASA: I and II
Gender: men and women




Number of participants: 50
Interventions Drug 1: 2% lido, isobaric, fixed dose (1 mL)
Drug 2: 0.5% bupi, isobaric, fixed dose (0.6 mL)
Needle: sharp-point
Outcomes TNS at 1, 3, and 7 days
Notes Follow-up duration: 7 days
Follow-up method: telephone contact
Ali Hassan 2015 
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TNS therapy: not described
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "fiHy patients were randomized by a computer generated random
number table and by 1:1 ratio into two groups of 25 each."
Allocation concealment
(selection bias)
Unclear risk No mention of allocation concealment.
Participant blinding (per-
formance bias and detec-
tion bias)
High risk Quote: "prospective, randomized, and open study was conducted (sic), includ-
ing 50 outpatients undergoing knee arthroscopy."
Provider blinding (perfor-
mance bias)
High risk Quote: "prospective, randomized, and open study was conducted (sic), includ-
ing 50 outpatients undergoing knee arthroscopy."
Assessor blinding (detec-
tion bias)
High risk Quote: "prospective, randomized, and open study was conducted (sic), includ-
ing 50 outpatients undergoing knee arthroscopy."




Low risk No dropouts.
Selective reporting (re-
porting bias)










ASA: I and II
Gender: women
Mean age: 31 (SD 5) years
Caesarean section
Surgical positioning: supine
Number of participants: 200
Interventions Drug 1: 5% lido, hyperbaric, fixed dose (1.5 mL)
Aouad 2001 
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Drug 2: 0.75% bupi, hyperbaric, fixed dose (1.6 mL)
Needle: 25 G, pencil-point
Outcomes TNS at 1 day
Back pain
Notes Follow-up duration: 1.3 days
Follow-up method: telephone contact
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "patients were allocated randomly by sealed envelope…"
Comment: did not specify the method of randomization (referring to a random




Unclear risk Quote: "patients were allocated randomly by sealed envelope…"
Comment: did not specify allocation by sequentially numbered, sealed,
opaque envelopes.
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "patients were blinded as to the spinal anesthetic used."
Provider blinding (perfor-
mance bias)
High risk Quote: "the anesthesiologist who administered the spinal anesthetic and




Low risk Quote: "all patients were interviewed… by an anesthesiologist who was un-




Low risk 200 participants enrolled. Results reported for 200 participants.
Selective reporting (re-
porting bias)
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ASA: I
Gender: men and women
Mean age (range): lido: 42 (20–57); levo: 39 (18–59); ropi: 39 (19–57) years
Ambulatory surgery
Surgical positioning: supine
Number of participants: 90
Interventions Drug 1: 2% lido, isobaric, fixed dose (3 mL)
Drug 2: 0.5% levo, isobaric, fixed dose (3 mL)
Drug 3: 0.75% ropi, isobaric, fixed dose (3 mL)
Needle: 27 G, pencil-point
Outcomes TNS at 2 days
Urinary retention
Notes Follow-up duration: 2 days
Follow-up method: telephone contact
TNS therapy: none
TNS resolution: 1 day
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote "…randomised (by a computer-generated randomisation sequence)…"
Allocation concealment
(selection bias)
Unclear risk Not described.
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "…double-blind study."
Provider blinding (perfor-
mance bias)
Low risk Quote: "…double-blind study." "All 3-ml solutions were prepared in an adja-
cent space by a supervisor not involved in the subsequent evaluation of the
study-patient."
Comment: we assume from this comment that the syringes were unlabelled.
Assessor blinding (detec-
tion bias)
Low risk Quote: "All 3-ml solutions were prepared in an adjacent space by a supervisor




Low risk Quote: "ninety patients…were included…" "Two days after discharge, all pa-
tients were contacted by phone…"
Comment: results reported for 90 participants.
Selective reporting (re-
porting bias)
Unclear risk Study protocol not available.
Breebaart 2003  (Continued)
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ASA: I and II
Gender: men and women
Mean age (range): lido: 49 (20–69); 2-chlorprocaine: 46 (18–70) years
Ambulatory surgery
Surgical positioning: supine
Number of participants: 30
Interventions Drug 1: 2% lido, isobaric, fixed dose (2.5 mL)
Drug 2: 2% 2-chlorprocaine isobaric, fixed dose (2.5 mL)
Needle: 25 G, pencil-point
Outcomes TNS during first 7 days
Notes Follow-up duration: 7 days
Follow-up method: telephone contact
TNS therapy: NSAID
TNS resolution: 7 days
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "using a computer-generated sequence of numbers, and sealed en-
velopes patients were randomly allocated to receive…(sic)."
Allocation concealment
(selection bias)
Unclear risk Quote. "using a computer-generated sequence of numbers, and sealed en-
velopes patients were randomly allocated to receive…(sic)."
Comment: did not specify allocation by sequentially numbered, sealed,
opaque envelopes.
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "…prospective, randomized, double-blind study…"
Provider blinding (perfor-
mance bias)
Low risk Quote: "the anesthesiologist performing the spinal injection, as well as the ob-
servers making assessments were blinded to patient grouping (sic)."
Casati 2007 
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Assessor blinding (detec-
tion bias)
Low risk Quote: "the anesthesiologist performing the spinal injection, as well as the ob-




Low risk No dropouts.
Selective reporting (re-
porting bias)








Dropouts: 1, outcome not reported
Participants Country: the Netherlands
ASA: I and II
Gender: men and women
Mean age: lido: 43 (SD 14); prilo: 37 (SD 11) years
Ambulatory surgery: unclear
Surgical positioning: supine
Number of participants: 70
Interventions Drug 1: 2% lido, isobaric, fixed dose (4 mL)
Drug 2: 2% prilo, isobaric, fixed dose (4 mL)
Needle: 25 G, pencil-point
Outcomes TNS at 1 day
Notes Follow-up duration: 1–4 days
Follow-up method: direct contact, telephone contact
TNS therapy: unclear
TNS resolution: 2–3 days
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "consecutive patients were randomly allocated using sealed en-
velopes…"
de Weert 2000 
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Comment: did not specify the method of randomization (referring to a random




Unclear risk Quote: "consecutive patients were randomly allocated using sealed en-
velopes…"
Comment: did not specify allocation by sequentially numbered, sealed,
opaque envelopes.
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "the purpose of this double-blind study…"
Comment: participants likely blinded.
Provider blinding (perfor-
mance bias)
Unclear risk Quote: "the purpose of this double-blind study…"
Comment: volume of local anaesthetic was same in each group, and study
was described as double-blind. However, there was no description of who pre-
pared the study drug.
Assessor blinding (detec-
tion bias)
Unclear risk Quote: "the purpose of this double-blind study…"




High risk Quote: "one patient in the prilocaine group could not be included because the
data were incomplete."
Comment: risk of bias was high because a single dropout may affect the esti-
mated risk of a rare event.
Selective reporting (re-
porting bias)










ASA: I and II
Gender: men and women
Age range: 18–60 years
Ambulatory surgery: no
Surgical positioning: supine, lithotomy
Number of participants: 250
Interventions Drug 1: 5% lido, hyperbaric, variable dose (1.5–2 mL)
Etezadi 2013 
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Drug 2: 0.5% bupi, isobaric, variable dose (2.5–3 mL)
Needle: 25 g sharp and pencil point
Outcomes TNS
Notes Follow-up duration: 5 days




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "… randomization was achieved by a computer-generated block of
numbers and sealed envelope technique."
Allocation concealment
(selection bias)
Unclear risk Quote: "… randomization was achieved by a computer-generated block of
numbers and sealed envelope technique."
Comment: did not specify allocation by sequentially numbered, sealed,
opaque envelopes.
Participant blinding (per-
formance bias and detec-
tion bias)








Low risk Quote: "the symptoms of TNS… were observed by a neurosurgeon that was




Low risk 250 participants enrolled, data reported for 250 participants.
Selective reporting (re-
porting bias)
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ASA: I and II
Gender: unclear
Age range: 18–80 years
Ambulatory surgery: yes
Surgical positioning: supine
Number of participants: 30
Interventions Drug 1: 1% lido, isobaric, fixed dose (5 mL)
Drug 2: 0.5% ropi, isobaric, fixed dose (2 mL)
Needle: 25 g, pencil-point
Outcomes TNS at 1 and 7 days
Notes Follow-up: 7 days
Follow-up method: telephone contact
TNS therapy: ketoprofen, tramadol
TNS resolution: by 7 days
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "using a computer-generated sequence of numbers for randomisation,
and sealed envelopes for allocation concealment, patients were allocated to
receive a spinal injection of either 50 mg of plain lidocaine 10 mg/ml or 10 mg
of plain ropivacaine 5 mg/ml."
Allocation concealment
(selection bias)
Unclear risk Quote: "using a computer-generated sequence of numbers for randomisation,
and sealed envelopes for allocation concealment…"
Comment: did not specify allocation by sequentially numbered, sealed,
opaque envelopes.
Participant blinding (per-
formance bias and detec-
tion bias)
Unclear risk Quote: "we therefore conducted a prospective, randomised, blind study…"
Comment: no description of participant blinding provided.
Provider blinding (perfor-
mance bias)
High risk Quote: "the anaesthesiologist performing the spinal block, who was aware of
patient's group allocation, was not involved in patient's follow-up."
Assessor blinding (detec-
tion bias)
Unclear risk Quote: "after spinal injection, a blinded observer recorded progression and re-
covery from the spinal block, until home discharge criteria were achieved."
Comment: no statement regarding the blinding status of the person perform-




Low risk No dropouts.
Fanelli 2009  (Continued)
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Selective reporting (re-
porting bias)











ASA: I and II
Gender: men and women
Age range: 20–81 years
Ambulatory surgery: no
Surgical positioning: supine
Number of participants: 60
Interventions Drug 1: 2% lido, isobaric, fixed dose (4 mL)
Drug 2: 0.5% levo, isobaric, fixed dose (4 mL)
Needle: sharp
Outcomes TNS at 3 days
Notes Follow-up duration: 7 days
Follow-up method: telephone contact
TNS therapy: NSAID
TNS resolution: 7 days
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "patients were assigned randomly by the authors…"




Unclear risk Quote: "patients were assigned randomly by the authors via a sealed envelope
method to receive either isobaric levobupivacaine HCl or isobaric lidocaine."
Gozdemir 2010 
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Comment: did not specify allocation by sequentially numbered, sealed,
opaque envelopes.
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "we enrolled 60 patients (47 male, 13 female, overall mean age 30 years
[range 20–81 years]) in this prospective, randomised, double-blind study."
Provider blinding (perfor-
mance bias)
Low risk Quote: "both drugs were prepared at 4 ml doses and were drawn into syringes
by an independent anaesthesia resident so that the anaesthetist performing
the injection was unaware of which drug was being given."
Assessor blinding (detec-
tion bias)
Low risk Quote: "the investigators performing the interviews were unaware of which




Low risk No dropouts.
Selective reporting (re-
porting bias)










ASA: I and II
Gender: women




Number of participants: 44
Interventions Drug 1: 5% lido, hyperbaric, fixed dose (1.5 mL)
Drug 2: 0.5% bupi, hyperbaric, fixed dose (1.5 mL)
Needle: 25 G, pencil-point
Outcomes TNS at 1 day
Back pain
Notes Follow-up duration: 1–4 days
Hampl 1995a 
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Follow-up method: direct contact
TNS therapy: unclear
TNS resolution: all recovered
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "patients were randomly assigned to receive one of the following three
local anesthetic solutions…"
Comment: did not specify the method of randomization (referring to a random




Unclear risk No mention of the method of allocation concealment (central allocation, se-
quentially numbered, sealed, opaque envelopes, or sequentially numbered
drug containers of identical appearance).
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "…the aim of this prospective double-blinded study was…"
Provider blinding (perfor-
mance bias)
Low risk Quote: "the drugs were delivered by the pharmacy in blinded vials each con-
taining 2 ml local anesthetic solution."
Assessor blinding (detec-
tion bias)
Low risk Quote: "on post-operative day 1, all patients were evaluated for TRI by oral in-





Low risk Quote "… we studied 44 ASA class I and II patients…"
Comment: results reported for 44 participants.
Selective reporting (re-
porting bias)










ASA: I and II
Gender: women
Mean age: lido: 39 (SD 17); prilo 39 (SD 13); bupi 36 (SD 14) years
Hampl 1998 
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Number of participants: 90
Interventions Drug 1: 2% lido, hyperbaric, fixed dose (2.5 mL)
Drug 2: 2% prilo, hyperbaric, fixed dose (2.5 mL)
Drug 3: 0.5% bupi, hyperbaric, fixed dose (2.5 mL)
Needle: 25 G, pencil-point
Outcomes TNS at 1 day
Notes Follow-up duration: 1–5 days
Follow-up methods: direct contact
TNS therapy: unclear
TNS resolution: 2–4 days
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Unclear risk No mention of method of allocation concealment.
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "the study solutions were provided by the hospital pharmacy… and
were provided in blinded vials."
Provider blinding (perfor-
mance bias)
Low risk Quote: "the study solutions were provided by the hospital pharmacy… and
were provided in blinded vials."
Assessor blinding (detec-
tion bias)
Low risk Quote: "…patients were evaluated for TNSs by a physician unaware of the
drug administered and the details of the anaesthetic procedure." (stated in ab-




Low risk Enrolled 90 participants, reported data for 90 participants.
Selective reporting (re-
porting bias)







Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)














ASA: I and II
Gender: men and women




Number of participants: 70
Interventions Drug 1: 5% lido, hyperbaric, fixed dose (1 mL)
Drug 2: 5% pro, hyperbaric, fixed dose (2 mL)
Needle: 24 and 25 G, pencil-point
Outcomes TNS at 1 day
Notes Follow-up duration: 3 days
Follow-up method: telephone contact
TNS therapy: unclear
TNS resolution: 48 hours
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "randomization was accomplished by random selection of blank,
closed envelopes assigned by a computer-generated scheme to lidocaine or
procaine by a numerical code which remained unbroken until data collection
and assessment of all patients was complete."
Allocation concealment
(selection bias)
Low risk Quote: "randomization was accomplished by random selection of blank,
closed envelopes assigned by a computer-generated scheme to lidocaine or
procaine by a numerical code which remained unbroken until data collection
and assessment of all patients was complete."
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "the patient remained blinded to the study drug."
Provider blinding (perfor-
mance bias)
High risk Quote: "…side effects…were managed intraoperatively by the managing anes-
thesia team, which was not blinded to the spinal drug."
Assessor blinding (detec-
tion bias)
Low risk Quote: "patients were contacted…by a single anesthesiologist blinded to the
agent that the patient had received."
Hodgson 2000  (Continued)
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)













Low risk Randomized 70 participants, results reported on 70 participants.
Selective reporting (re-
porting bias)











ASA: I and II
Gender: men and women
Age range: 20–60 years
Ambulatory surgery: yes
Surgical positioning: prone jack-knife
Number of participants: 150
Interventions Drug 1: 0.6% lido, hypobaric, fixed dose (3 mL)
Drug 2: 0.15% bupi, hypobaric, fixed dose (3 mL)
Needle: 27 G, sharp
Outcomes TNS
Notes Follow-up duration: 30 days
Follow-up method: telephone contact
TNS therapy: not available
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "the randomized sequence was generated by a computer…"
Allocation concealment
(selection bias)
Unclear risk Quote: "the randomized sequence was generated by a computer, which was
followed by the preparation of coded envelopes."
Imbelloni 2010 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)
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Comment: did not specify allocation by sequentially numbered, sealed,
opaque envelopes.
Participant blinding (per-
formance bias and detec-
tion bias)




Low risk Quote: "both solutions were prepared by an anesthesiologist who did not par-
ticipate in the study."
Assessor blinding (detec-
tion bias)
Unclear risk Quote: "proprioception and sensorial blockade were assessed by another
anesthesiologist, who was not aware of the groups…"
Comment: although the person assessing block characteristics was blinded,




Low risk No dropouts.
Selective reporting (re-
porting bias)








Dropouts: 1 outcome reported
Participants Country: Denmark
ASA: I and II
Gender: men and women
Mean age: lido: 43; bupi: 46 years
Procedures: orthopaedic, general surgery
Ambulatory surgery: unclear
Surgical positioning: supine
Number of participants: 70
Interventions Drug 1: 5% lido, hyperbaric, fixed dose (2 mL)
Drug 2: 0.5% bupi, hyperbaric, fixed dose (2.5 mL)
Needle: 25 G, pencil-point
Outcomes TNS at 1 day
Back pain
Keld 2000 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)
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Notes Follow-up duration: 1–3 days
Follow-up methods: telephone contact
TNS therapy: unclear
TNS resolution: 41 hours
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "the patients were randomised to receive…" did not specify the
method of randomisation (referring to a random number table, computer-gen-
erated random number sequence, tossing coin, etc.).
Allocation concealment
(selection bias)
Unclear risk No mention of allocation concealment.
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "the study was performed as a prospective double-blinded study…"
Provider blinding (perfor-
mance bias)
High risk Quote: "this anaesthesiologist used the local anaesthetic according to the ran-
dom patient number and was therefore not blinded to the anaesthetic used."
Assessor blinding (detec-
tion bias)
Low risk Quote: "the patient was contacted… by a different anaesthesiologist, who was




High risk Quote: "one patient in the bupivacaine group received general anaesthesia
due to insufficient spinal anaesthesia and was excluded from the study."
Comment: outcome from dropout not reported.
Selective reporting (re-
porting bias)








Dropouts: 6 outcomes not reported
Participants Country: Canada
ASA: I and II
Gender: men and women
Mean age: lido: 38 (SD 9); pro: 41 (SD 11) years
Procedures: general surgery, gynaecological
Le Truong 2001 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)
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Ambulatory surgery: unclear
Surgical positioning: supine, lithotomy
Number of participants: 66
Interventions Drug 1: 5% lido, hyperbaric, fixed dose (2 mL)
Drug 2: 10% pro, baricity unclear, fixed dose (1 mL)
Needle: 27 G, pencil point
Outcomes TNS at 2 days





Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "patients were randomized to receive…"
Comment: did not specify the method of randomization (referring to a random




Unclear risk No mention of allocation concealment.
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "this randomized, double-blind, prospective study…"
Provider blinding (perfor-
mance bias)
Unclear risk Quote: "this randomized, double-blind, prospective study…"




Low risk Quote: "a blinded observer noted…" "…a blinded observer contacted the pa-




High risk Quote: "five patients had inadequate surgical anesthesia in group P… and one
in group L. All required general anesthesia and were excluded from the final
data analysis."
Comment: outcomes not reported from dropouts.
Selective reporting (re-
porting bias)






Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
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Dropouts: 3 outcomes not reported
Participants Country: USA
ASA: I, II, and III
Gender: men and women




Number of participants: 60
Interventions Drug 1: 2% lido, baricity unclear, fixed dose (3 mL)
Drug 2: 1.5% mepi, baricity unclear, fixed dose (3 mL)
Needle: 27 G, pencil-point
Outcomes TNS at 1–2 days
Notes Follow-up duration: 2–5 days
Follow-up method: telephone contact
TNS therapy: NSAIDs
TNS resolution: duration 1–5 days
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "the patients were assigned using a random-number table to receive
either 2% 3 ml (60 mg) lidocaine… or 1.5% 3 ml (45 mg) mepivacaine…"
Allocation concealment
(selection bias)
Unclear risk No mention of allocation concealment.
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "…we decided to re-evaluate mepivacaine… in a randomized, dou-
ble-blind comparison with isobaric 2% lidocaine…"
Provider blinding (perfor-
mance bias)
Low risk Quote: "…we decided to re-evaluate mepivacaine… in a randomized, dou-
ble-blind comparison with isobaric 2% lidocaine…"
Assessor blinding (detec-
tion bias)
Low risk Quote: "patients were contacted… by one of the investigators who was blind-
ed to group assignment."
Incomplete outcome data
(attrition bias) 
High risk 3 participants in lido group lost to follow-up. Dropout outcomes not reported.
Liguori 1998  (Continued)
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)





















Dropouts: 2 outcomes reported
Participants Country: Spain
ASA: I, II, and III
Gender: men and women
Age range: 18–80 years
Procedures: orthopaedic, urological, gynaecological, vascular, general surgery
Ambulatory surgery: unclear
Surgical positioning: supine, prone, lithotomy
Number of participants: 200
Interventions Drug 1: 5% lido, hyperbaric, variable dose
Drug 2: 5% prilo, hyperbaric, variable dose
Needle: 25 G, pencil-point
Outcomes TNS at 1–2 days
Back pain
Notes Follow-up duration: 3–5 days
Follow-up method: direct contact, telephone contact
TNS therapy: NSAIDs
TNS resolution: maximum duration 10 days
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "the patients were assigned… according to a computer-generated list
by simple random sampling."
Allocation concealment
(selection bias)
Low risk Quote: "patients were numbered consecutively by a blinded observer and allo-
cated to one of the anaesthetic solutions."
Martinez-Bourio 1998 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)
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Participant blinding (per-
formance bias and detec-
tion bias)
Unclear risk Quote: "this prospective, masked, randomized study…"
Comment: participant blinding not mentioned.
Provider blinding (perfor-
mance bias)
High risk Quote: "the anesthetist who administered the spinal anesthesia (and collected
the data on sensory and motor block) was not blinded to the study groups."
Assessor blinding (detec-
tion bias)
Low risk Quote: "all patients were contacted by telephone 3–5 days after spinal anes-





Low risk Quote: "two blocks in the prilocaine group provided inadequate surgical anes-
thesia, and general anesthesia was required. None of the two patients with in-
adequate spinal anesthesia reported TNSs, but these patients were excluded
from the final analysis…"
Comment: although these participants were excluded from the final analysis,
the authors reported the outcome of interest. Therefore, risk of bias was low.
Selective reporting (re-
porting bias)









Dropouts: 7 dropouts, outcomes not reported
Participants Country: USA
ASA I, II, and III
Gender: unclear
Age range: 19–70 years
Ambulatory surgery: yes
Surgical positioning: supine
Number of participants: 84
Interventions Drug 1: 2% lido, isobaric, fixed dose (4 mL)
Drug 2: 2% mepi, isobaric, fixed dose (4 mL)
Needle: 27 G, pencil-point
Outcomes TNS
Notes Follow-up duration: 3 days
Pawlowski 2012 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)
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Follow-up method: telephone contact
TNS therapy: not available
TNS resolution: not available
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Unclear risk Did not discuss allocation concealment.
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "the purpose of this prospective, randomized, double-blinded study…"
Provider blinding (perfor-
mance bias)
Low risk Quote: "the lidocaine and mepivacaine solutions for subarachnoid injection
were prepared by an investigator who did not participate in the patients' anes-
thetic care or data collection."
Assessor blinding (detec-
tion bias)
Low risk Quote: "a study-blinded observer assessed level of sensory block bilaterally
using a plastic pencil-point needle along the lumbar and thoracic dermatomes
in the midaxillary line." "Information on delayed variables, including fatigue,
nausea, vomiting, difficulty urinating, pain at the spinal needle site, pain at the
surgical site, back pain, back pain with radiating pain to the buttocks and/or
lower extremities (TNS), and numbness and tingling sensations, were obtained




High risk Dropout outcomes not reported.
Selective reporting (re-
porting bias)












Mean age: lido: 27 (SD 5); bupi: 25 (SD 4) years
Philip 2001 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)
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Procedures: postpartum tubal ligation
Ambulatory surgery: no
Surgical positioning: supine
Number of participants: 58
Interventions Drug 1: 5% lido, hyperbaric, variable dose
Drug 2: 0.75% bupi, hyperbaric, variable dose
Needle: 25 G, pencil-point
Outcomes TNS at 1 day
Back pain
Notes Follow-up duration: 3 weeks
Follow-up method: direct contact
TNS therapy: unclear
TNS resolution: complete recovery at 2 days
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "they were assigned to receive either… lidocaine or … bupivacaine in a
double-blinded manner using a computer-generated randomisation scheme."
Allocation concealment
(selection bias)
Unclear risk No mention of the method of allocation concealment.
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "they were assigned to receive either… lidocaine or … bupivacaine in a
double-blinded manner using a computer-generated randomisation scheme."
Provider blinding (perfor-
mance bias)
Low risk Quote: "they were assigned to receive either… lidocaine or … bupivacaine in a
double-blinded manner using a computer-generated randomisation scheme."
"The local anaesthetic solutions were prepared by the hospital pharmacy…
and delivered in blinded vials."
Assessor blinding (detec-
tion bias)
Low risk Quote: "…the patients were then interviewed… at 24 and 48 h [hours] postop-




Low risk Quote: "one patient who received lidocaine was excluded from our analysis
because of an inadequate block that required general anesthesia. This patient
did not develop any postoperative symptoms."
Comment: although these participants were excluded from the final analysis,




Unclear risk Study protocol not available.
Philip 2001  (Continued)
 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
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Dropouts: 7 outcomes reported
Participants Country: USA
ASA: I and II
Gender: men and women
Mean age: lido 1.2 mL: 52 (SD 16); lido 3.0 mL: 51 (SD 13); lido 1.5 mL: 53 (SD 12); lido 3.75 mL: 59 (SD




Number of participants: 159
Interventions Drug 1: 2%, 5% lido; hyperbaric, isobaric; fixed dose (1.2, 3.0, 1.5, 3.75 mL)
Drug 2: 0.75% bupi, hyperbaric, fixed dose (1.0, 1.2 mL)
Needle: 22 and 25 G, cutting and pencil-point
Outcomes TNS at 3 days
Back pain
Notes Follow-up duration: 3–14 days
Follow-up method: telephone contact
TNS therapy: NSAIDs, opioids
TNS resolution: no symptoms at 14 days
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "patients were… randomized by sealed envelope."
Comment: Cochrane criteria for low risk of bias requires allocation by "se-
quentially numbered, sealed, opaque envelopes."
Allocation concealment
(selection bias)
Unclear risk Quote: "patients were… randomized by sealed envelope."
Comment: did not specify allocation by sequentially numbered, sealed,
opaque envelopes.
Pollock 1996 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)
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Participant blinding (per-
formance bias and detec-
tion bias)




High risk Quote. "…patients…were randomized and stratified in a double-blinded fash-
ion…"
Comment: the volume of local anaesthetic was different between the 2 groups,




Low risk Quote: "time to block resolution was defined as the time that a blinded PACU
nurse could no longer detect presence of anesthesia by pinprick or alcohol





Low risk Quote: "none of the seven subjects with inadequate spinal anesthesia report-
ed TRI, but these patients were excluded from final data analysis because of
the possibility that local anaesthetic was not placed intrathecally."
Comment: 5 from the lido groups, 2 from the bupi group. Although these par-
ticipants were excluded from the final analysis, the authors reported the out-
come of interest. Therefore, the risk of bias was low.
Selective reporting (re-
porting bias)
















Number of participants: 52
Interventions Drug 1: 5% lido, hyperbaric, fixed dose (1.5 mL)
Drug 2: 0.5% bupi, hyperbaric, fixed dose (2.2 mL)
Pradhan 2010 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)
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Needle: 26 G, sharp-point
Outcomes TNS at 1 day
Notes Follow-up duration: 1 days
Follow-up method: direct contact
TNS therapy: not described
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote. "the patients were randomly divided into two groups… according to
the group in closed envelope upon arrival in operation (sic) theatre."
Comment: did not describe method of randomization.
Allocation concealment
(selection bias)
Low risk Quote. "the patients were randomly divided into two groups… according to
the group in closed envelope upon arrival in operation (sic) theatre."
Comment: although allocation concealment was not mentioned, the implied
sequence of enrolment in the study and then allocated to a group in the oper-
ating room suggested allocation concealment.
Participant blinding (per-
formance bias and detec-
tion bias)
Unclear risk No mention of blinding participants to group assignment.
Provider blinding (perfor-
mance bias)
High risk No mention of blinding anaesthesiologists to group assignment and volume of
drug administered intrathecally was different according to group assignment.
Assessor blinding (detec-
tion bias)
High risk No mention of blinding assessor to group assignment and no mention of the




Unclear risk 52 participants enrolled. Dropouts not mentioned; unclear for how many par-
ticipant results were reported.
Selective reporting (re-
porting bias)








Dropouts: 1 outcome not reported
Participants Country: Spain
ASA: I and II
Salazar 2001 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)
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Gender: men and women




Number of participants: 81
Interventions Drug 1: 2% lido, isobaric, variable dose
Drug 2: 2% mepi, isobaric, variable dose
Needle: 26 and 27 G, cutting
Outcomes TNS at 1 day
Notes Follow-up duration: 1+ days
Follow-up method: direct contact
TNS therapy: NSAIDs
TNS resolution: 1 day
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "they were randomized in two groups of 40 patients each…"
Comment: did not specify the method of randomization (referring to a random




Unclear risk Quote: "eighty consecutive patients…"
Comment: no mention was made regarding allocation concealment. Noting
that the investigators enrolled eighty consecutive participants, the risk of bias
may have been low.
Participant blinding (per-
formance bias and detec-
tion bias)
Unclear risk No mention made of participant blinding.
Provider blinding (perfor-
mance bias)
High risk Quote: "the anaesthesiologist who administered the spinal anaesthesia and




Low risk Quote: "…the anaesthesiologist assessing the postoperative incidence of TNS




Low risk 80 participants enrolled, results reported for 80 participants.
Selective reporting (re-
porting bias)
Unclear risk Study protocol not available.
Salazar 2001  (Continued)
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ASA: I, II, III, and IV
Gender: 74 men, 16 women
Age range: 29–91 years
Procedures: urological
Ambulatory surgery: unclear
Surgical positioning: supine, lithotomy
Number of participants: 90
Interventions Drug 1: 5% lido, hyperbaric, variable dose
Drug 2: 0.5% bupi, hyperbaric, variable dose
Drug 3: 4% mepi, hyperbaric, variable dose
Needle: 25 and 27 G, cutting and pencil-point
Outcomes TNS at 1 day
Notes Follow-up duration: 1 day
Follow-up method: direct contact
TNS therapy: NSAIDs, opioids
TNS resolution: 1–2 days
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "…consecutive patients were randomized using sealed envelopes…"
Comment: no mention of randomization scheme.
Allocation concealment
(selection bias)
Unclear risk Quote. "…consecutive patients were randomized using sealed envelopes…"
Comment: did not specify allocation by sequentially numbered, sealed,
opaque envelopes.
Participant blinding (per-
formance bias and detec-
tion bias)
Unclear risk No mention of participant blinding or characterization of the study as "dou-
ble-blind."
Salmela 1998 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
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Provider blinding (perfor-
mance bias)
High risk The anaesthesiologist performing the subarachnoid block varied the dose of
local anaesthetic depending on the anticipated duration of the surgery. There




Low risk Quote: "the patients were interviewed using a standardized questionnaire on
the first postoperative day by an anesthesiologist who did not know which




Low risk Outcomes reported for all participants.
Selective reporting (re-
porting bias)








Dropouts: 7 reported (2 in 2-chloroprocaine group, 4 in lido group, 1 in bupi group)
Participants Country: Belgium
ASA: I, II, and III
Gender: men, women




Number of participants: 99
Interventions Drug 1: 1% lido 40 mg
Drug 2: 1% preservative-free 2-chloroprocaine 40 mg
Drug 3: 0.5% bupi 7.5 mg
Needle: 27 G, 103 mm Whitacre needle
Outcomes TNS at day 1
Time until complete recovery of the sensory block
Notes All dosages in every intervention arm were diluted with saline to a total volume of 4.5 mL in an unla-
belled syringe.
Teunkens 2016 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Low risk Quote. "allocation concealment was ensured by enclosing assignments in
sealed, opaque, sequentially numbered envelopes, which were opened only
after arrival of the patient in the operating room."
Participant blinding (per-
formance bias and detec-
tion bias)
Low risk Quote: "this prospective, double-blind, randomized, controlled clinical trial…"
Provider blinding (perfor-
mance bias)
Low risk Quote: "all dosages [of study medication] were diluted with saline to a total
volume of 4.5 ml in an unlabeled syringe. The study medication was prepared
by a consultant staD member of the Department of Anesthesiology who was
not further involved in the perioperative care of the respective patients or in
data gathering and study visits."
Assessor blinding (detec-
tion bias)
Low risk Quote: "all data were collected by the study nurse of the department who was




High risk Outcomes not reported for 7 participants.
Selective reporting (re-
porting bias)
Low risk Primary and secondary outcomes consistent with study protocol 2011-003675








Dropouts: 4 GA, outcomes reported
Participants Country: Norway
ASA: unclear
Gender: men and women
Mean ages: lido: 65 (SD 17); prilo: 69 (SD 12) years
Procedures: urological
Ambulatory surgery: unclear
Surgical positioning: supine, lithotomy
Number of participants: 100
Østgaard 2000 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
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Interventions Drug 1: 2% lido, isobaric, fixed dose (4 mL)
Drug 2: 2% prilo, isobaric, fixed dose (4 mL)
Needle: 25, 26, 27, and 29 G, cutting
Outcomes TNS at 1 day
Other pain
Notes Follow-up duration: 1 day




Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Quote: "patients were randomised in the morning using sealed envelopes…"
Comment: did not specify the method of randomization (referring to a random




Low risk Quote: "patients were randomized in the morning using sealed envelopes…"
Comment: although this description was less detailed than the Cochrane stan-
dard for low risk of bias (sequentially numbered, opaque, sealed envelopes),
the sequent of enrolling participants the day before surgery and randomizing
on the day of surgery suggests allocation concealment probably happened.
Participant blinding (per-
formance bias and detec-
tion bias)
Unclear risk Did not specify participant blinding.
Provider blinding (perfor-
mance bias)
Unclear risk No mention made of blinding, study drug, or double-blind study construction.
Assessor blinding (detec-
tion bias)
Low risk Quote: "the following day the patients were interviewed by an anesthesiolo-




Unclear risk Description of number of participants enrolled and participant data reported
were inconsistent. (Abstract stated 100 participants enrolled, methods section
of the text stated 90 participants enrolled, data for 99 participants were report-
ed.) 4 participants received GA and their results were reported.
Selective reporting (re-
porting bias)
Unclear risk Study protocol not available.
Østgaard 2000  (Continued)
All the study were randomized controlled trials.
ASA: American Society of Anesthesiologist Physical Status Score (I, II, III, and IV); bupi: bupivacaine; G: gauge; GA: general anaesthesia; levo:
levobupivacaine; lido: lidocaine; mepi: mepivacaine; NSAID: non-steroidal anti-inflammatory drug; PACU: postanaesthesia care unit; prilo:
prilocaine; pro: procaine; ropi: ropivacaine; SD: standard deviation; TNS: transient neurological symptoms.
None of the studies mentioned any financial support of pharmaceutical companies or other competing interests.
In the case of unclear biases, attempts were made to obtain more information from the authors.
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Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Ben-David 2000 Fentanyl plus lidocaine. No arm with another local anaesthetic.
Bergeron 1999 No lidocaine, only 1 arm with procaine, risk of TNS: 1/62 participants, but high risk of nausea.
Chan 1998 Continuous spinal anaesthesia with lidocaine 5%. No follow-up, no mention of TNS.
Chohedri 2015 Combined 2 local anaesthetics.
de Santiago 2010 Combined local anaesthetic and fentanyl.
Frey 1998 Volunteers and no surgery.
12 participants. Crossover: lidocaine 5% (100 mg), tetracaine 1% (30 mg) and bupivacaine 0.75%
(15 mg)
3/12 participants had TNS, it was quite unpleasant, unable to sit and needed NSAID.
Gentili 1997 No lidocaine. Bupivacaine 0.1%, 0.15%, and 0.2%. Volume: 4 mL. 90 participants, 0 cases of TNS.
Hampl 1995b Non-randomized study
Hampl 1996 Lidocaine in 2 different concentrations: 5% vs 2%. No difference in the risk of TNS (8/25 with 5% li-
docaine vs 10/25 with 2% lidocaine). Reduction in concentration did not reduce the risk of TNS.
Henderson 1998 Case history: 1 participant with TNS after 1% lidocaine 40 mg. Full recovery.
Hiller 1999 Only 1 arm with lidocaine: second arm with general anaesthesia. Even participants who receive on-
ly general anaesthesia can develop TNS.
Imbelloni 2008a Only hyperbaric lidocaine: 2 arms with 2 mL 1.5% vs 1.5 mL 2%.
Imbelloni 2008b Only hypobaric lidocaine: 3 arms with 3 mL 0.6% vs 4 mL 0.6% vs 5 ml 0.6%.
Jacobsen 2011 Combination of local anaesthetics.
Lee 2008 Combination of local anaesthetics.
Liam 1998 Only lidocaine: 3 arms with 1% lidocaine in different volumes: 4 mL, 6 mL, and 8 mL. No cases of
TNS.
Loo 1999 Swedish Pharmacological Insurance reported 6 cases of cauda equina syndrome between 1993
and 1997. 5 cases after single spinal injection of lidocaine 5% and 1 case after repeated injection.
Lidocaine doses was 60–100 mg. All cases sustained permanent neurological deficits. Recommen-
dation: use 2% lidocaine and no more than 60 mg.
Markey 1997 1.5% lidocaine was as effective an anaesthetic as 5% for participants undergoing hernia operation.
No mention of TNS.
Mgbakor 2012 Non-randomized study, did not report TNS.
Morisaki 1998 Non-randomized study: 4/1045 participants who received lidocaine 3% 45 mg (for anorectal
surgery) had TNS.
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Study Reason for exclusion
Murto 1999 Intrathecal meperidine 0.3 mg/kg was added to lidocaine to prolong postoperative analgesia. No
mention of TNS.
Pawlowski 2000 No lidocaine. Mepivacaine 1.5% (60 mg) and 2% (80 mg) was used in 60 participants. Follow-up at
24 hours: 0 cases of TNS.
Pollock 1999 Only lidocaine was used: 3 arms with 0.5%, 1%, and 2% lidocaine: risk of TNS was not concentra-
tion-dependant (20/109 participants).
Punj 2013 Authors contacted several times to request unavailable data, without any response.
Salmela 1996 Only 1 arm with lidocaine 5%. 13/44 urological participants had signs of TNS.
Sia 1998 3 cases of TNS after spinal mepivacaine.
Tong 2003 Only lidocaine was used, 2 arms with lidocaine 80 mg: 1% (218 participants) and 5% hyperbaric li-
docaine (235 participants); risk of TNS was not concentration-dependant (21% with 1% lidocaine
vs 18% with 5% lidocaine).
Vaghadia 2012 Local anaesthetic combined with opioid.
Wong 1999 Non-randomized study.
Yazicioglu 2013 Combination of local anaesthetics.
Zayas 1999 No lidocaine. Dose–response study for spinal mepivacaine 1.5%, 25 participants. 40 mg, 45 mg, and
60 mg: 5 cases of TNS out of 75 participants; irrespective of mepivacaine doses.
NSAIDs: non-steroidal anti-inflammatory drugs; TNS: transient neurological symptoms.
 
Characteristics of studies awaiting assessment [ordered by study ID]
 
Methods Not yet assessed
Participants Not yet assessed
Interventions Not yet assessed
Outcomes Not yet assessed




Methods Not yet assessed
Participants Not yet assessed
Interventions Not yet assessed
Outcomes Not yet assessed
Gozdemir 2016 
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Notes Not yet assessed
Gozdemir 2016  (Continued)
 
Characteristics of ongoing studies [ordered by year of study]
 
Trial name or title Comparison of lidocaine versus bupivacaine spinal anesthesia in total hip arthroplasty: a random-
ized, double-blind, prospective study
Methods Allocation: randomized
Intervention model: parallel assignment
Blinding: triple (participant, investigator, outcomes assessor)
Participants 186 participants receiving total hip arthroplasty through anterior approach with lidocaine spinal
anaesthesia and completing telephone questionnaires to see how they are feeling postoperation.
Interventions Drug 1: lidocaine
Drug 2: bupivacaine
Outcomes Transient neurological symptoms at 1–3 days postoperation
Transient neurological symptoms at 1–7 days postoperation
Transient neurological symptoms at 7–14 days postoperation
Starting date September 2016
Contact information Ashley Freeman
asroka@emory.edu
Notes Recruiting




D A T A   A N D   A N A L Y S E S
 
Comparison 1.   One local anaesthetic versus a di:erent local anaesthetic





Statistical method Effect size
1 Presence of any transient
neurological symptoms
24   Risk Ratio (IV, Random, 95% CI) Subtotals only
1.1 Bupivacaine vs lidocaine 12 1220 Risk Ratio (IV, Random, 95% CI) 0.16 [0.09, 0.28]
1.2 2-Chlorprocaine vs lido-
caine
2 94 Risk Ratio (IV, Random, 95% CI) 0.09 [0.01, 1.51]
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
patients: a network meta-analysis (Review)









Cochrane Database of Systematic Reviews





Statistical method Effect size
1.3 Levobupivacaine vs lido-
caine
2 120 Risk Ratio (IV, Random, 95% CI) 0.13 [0.02, 0.69]
1.4 Mepivacaine vs lidocaine 4 274 Risk Ratio (IV, Random, 95% CI) 1.01 [0.18, 5.82]
1.5 Prilocaine vs lidocaine 4 429 Risk Ratio (IV, Random, 95% CI) 0.18 [0.07, 0.49]
1.6 Procaine vs lidocaine 2 130 Risk Ratio (IV, Random, 95% CI) 0.14 [0.04, 0.52]
1.7 Ropivacaine vs lidocaine 2 90 Risk Ratio (IV, Random, 95% CI) 0.10 [0.01, 0.78]
1.8 Bupivacaine vs mepiva-
caine
1 60 Risk Ratio (IV, Random, 95% CI) 0.04 [0.00, 0.71]
1.9 Bupivacaine vs prilocaine 1 60 Risk Ratio (IV, Random, 95% CI) 0.33 [0.01, 7.87]
1.10 Levobupivacaine vs ropi-
vacaine
1 60 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
1.11 Bupivacaine vs 2-chlorp-
rocaine
1 67 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 1.1.   Comparison 1 One local anaesthetic versus a di:erent local
anaesthetic, Outcome 1 Presence of any transient neurological symptoms.




Risk Ratio Weight Risk Ratio
  n/N n/N IV, Random, 95% CI   IV, Random, 95% CI
1.1.1 Bupivacaine vs lidocaine  
Ali Hassan 2015 0/25 0/25   Not estimable
Aouad 2001 0/100 0/100   Not estimable
Etezadi 2013 14/125 85/125 71.07% 0.16[0.1,0.27]
Hampl 1995a 0/16 9/28 4.02% 0.09[0.01,1.45]
Hampl 1998 0/30 9/30 3.96% 0.05[0,0.87]
Imbelloni 2010 0/75 0/75   Not estimable
Keld 2000 1/35 9/35 7.51% 0.11[0.01,0.83]
Philip 2001 2/28 1/30 5.59% 2.14[0.21,22.35]
Pollock 1996 0/52 16/107 3.98% 0.06[0,1.01]
Pradhan 2010 0/26 0/26   Not estimable
Salmela 1998 0/30 6/30 3.87% 0.08[0,1.31]
Teunkens 2016 0/35 0/32   Not estimable
Subtotal (95% CI) 577 643 100% 0.16[0.09,0.28]
Total events: 17 (Local anaesthetic 1), 135 (Local anaesthetic 2)  
Heterogeneity: Tau2=0.05; Chi2=6.31, df=6(P=0.39); I2=4.98%  
Test for overall effect: Z=6.35(P<0.0001)  
   
1.1.2 2-Chlorprocaine vs lidocaine  
Casati 2007 0/15 5/15 100% 0.09[0.01,1.51]
Teunkens 2016 0/32 0/32   Not estimable
Favours leH column 2000.005 100.1 1 Favours right column
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Risk Ratio Weight Risk Ratio
  n/N n/N IV, Random, 95% CI   IV, Random, 95% CI
Subtotal (95% CI) 47 47 100% 0.09[0.01,1.51]
Total events: 0 (Local anaesthetic 1), 5 (Local anaesthetic 2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.67(P=0.09)  
   
1.1.3 Levobupivacaine vs lidocaine  
Breebaart 2003 0/30 3/30 32.27% 0.14[0.01,2.65]
Gozdemir 2010 1/30 8/30 67.73% 0.13[0.02,0.94]
Subtotal (95% CI) 60 60 100% 0.13[0.02,0.69]
Total events: 1 (Local anaesthetic 1), 11 (Local anaesthetic 2)  
Heterogeneity: Tau2=0; Chi2=0.01, df=1(P=0.94); I2=0%  
Test for overall effect: Z=2.41(P=0.02)  
   
1.1.4 Mepivacaine vs lidocaine  
Liguori 1998 0/30 6/27 22.48% 0.07[0,1.18]
Pawlowski 2012 0/37 0/40   Not estimable
Salazar 2001 3/40 1/40 29.08% 3[0.33,27.63]
Salmela 1998 11/30 6/30 48.45% 1.83[0.78,4.32]
Subtotal (95% CI) 137 137 100% 1.01[0.18,5.82]
Total events: 14 (Local anaesthetic 1), 13 (Local anaesthetic 2)  
Heterogeneity: Tau2=1.45; Chi2=5.11, df=2(P=0.08); I2=60.85%  
Test for overall effect: Z=0.02(P=0.99)  
   
1.1.5 Prilocaine vs lidocaine  
de Weert 2000 0/35 7/35 12.3% 0.07[0,1.12]
Hampl 1998 1/30 9/30 24.48% 0.11[0.01,0.82]
Martinez-Bourio 1998 1/102 4/98 20.78% 0.24[0.03,2.11]
Østgaard 2000 2/50 7/49 42.43% 0.28[0.06,1.28]
Subtotal (95% CI) 217 212 100% 0.18[0.07,0.49]
Total events: 4 (Local anaesthetic 1), 27 (Local anaesthetic 2)  
Heterogeneity: Tau2=0; Chi2=1.09, df=3(P=0.78); I2=0%  
Test for overall effect: Z=3.38(P=0)  
   
1.1.6 Procaine vs lidocaine  
Hodgson 2000 2/35 11/35 79.37% 0.18[0.04,0.76]
Le Truong 2001 0/30 8/30 20.63% 0.06[0,0.98]
Subtotal (95% CI) 65 65 100% 0.14[0.04,0.52]
Total events: 2 (Local anaesthetic 1), 19 (Local anaesthetic 2)  
Heterogeneity: Tau2=0; Chi2=0.49, df=1(P=0.48); I2=0%  
Test for overall effect: Z=2.98(P=0)  
   
1.1.7 Ropivacaine vs lidocaine  
Breebaart 2003 0/30 3/30 47.74% 0.14[0.01,2.65]
Fanelli 2009 0/15 6/15 52.26% 0.08[0,1.25]
Subtotal (95% CI) 45 45 100% 0.1[0.01,0.78]
Total events: 0 (Local anaesthetic 1), 9 (Local anaesthetic 2)  
Heterogeneity: Tau2=0; Chi2=0.09, df=1(P=0.76); I2=0%  
Test for overall effect: Z=2.2(P=0.03)  
   
1.1.8 Bupivacaine vs mepivacaine  
Salmela 1998 0/30 11/30 100% 0.04[0,0.71]
Favours leH column 2000.005 100.1 1 Favours right column
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Risk Ratio Weight Risk Ratio
  n/N n/N IV, Random, 95% CI   IV, Random, 95% CI
Subtotal (95% CI) 30 30 100% 0.04[0,0.71]
Total events: 0 (Local anaesthetic 1), 11 (Local anaesthetic 2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.2(P=0.03)  
   
1.1.9 Bupivacaine vs prilocaine  
Hampl 1998 0/30 1/30 100% 0.33[0.01,7.87]
Subtotal (95% CI) 30 30 100% 0.33[0.01,7.87]
Total events: 0 (Local anaesthetic 1), 1 (Local anaesthetic 2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.68(P=0.5)  
   
1.1.10 Levobupivacaine vs ropivacaine  
Breebaart 2003 0/30 0/30   Not estimable
Subtotal (95% CI) 30 30 Not estimable
Total events: 0 (Local anaesthetic 1), 0 (Local anaesthetic 2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
1.1.11 Bupivacaine vs 2-chlorprocaine  
Teunkens 2016 0/35 0/32   Not estimable
Subtotal (95% CI) 35 32 Not estimable
Total events: 0 (Local anaesthetic 1), 0 (Local anaesthetic 2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours leH column 2000.005 100.1 1 Favours right column
 
 
A D D I T I O N A L   T A B L E S
 
Study ID TNS #/N (%) Pain score (0–10) TNS duration Therapy
Aouad 2001 0/100 (0) — — —
Breebaart 2003 3/30 (10) Not tallied 1 day Not described
Casati 2007 5/15 (33) Not tallied Up to 7 days NSAIDs
de Weert 2000 7/35 (20) Day 1 mean VPS 5.3
(range 2–8)
Maximum duration 3 days Not described
Etezadi 2013 85/135 (63) Mean VAS 6–7 Maximum duration 5 days NSAIDs
Fanelli 2009 6/15 (40) Not tallied Resolved within 7 days Not described
Gozdemir 2010 8/30 (27) Median VPS 3 (range 1–6) Resolved within 7 days Not described
Hampl 1995a 9/28 (32) Not tallied Maximum duration 4 days Not described
Table 1.   Studies reporting transient neurological symptoms aKer intrathecal lidocaine 
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Hampl 1998 9/30 (30) Mean maximum VAS 3.75 Maximum duration 2 days Not described
Ali Hassan 2015 0/25 (0) — — —
Hodgson 2000 11/35 (31) Mean VPS 5 Mean duration 2 days Not described
Imbelloni 2010 0/75 (0) — — —
Keld 2000 9/35 (26) Mean VPS 3.5 (range 2–8) Maximum duration 4 days Not described
Le Truong 2001 8/30 (27) Not tallied Unspecified Not described
Liguori 1998 6/27 (22) Not tallied Maximum duration 5 days NSAIDs
Martinez-Bourio 1998 4/98 (4) Not tallied Maximum duration 10 days NSAIDs
Østgaard 2000 7/49 (14) VPS range 5–9.5 Maximum duration 3 days Not described
Pawlowski 2012 0/40 (0) — — —
Philip 2001 1/30 (3) Maximum VAS 3 Maximum duration 2 days Not described
Pollock 1996 16/107 (15) Mean VPS 6.2 (range 1–9) Maximum duration 4 days NSAIDs and opi-
oids
Pradhan 2010 0/26 (0) — — —
Salazar 2001 1/40 (3) Maximum VAS 9–10 Maximum duration 1 day NSAIDs
Salmela 1998 6/30 (20) Moderate pain Maximum duration 1 day NSAIDs and opi-
oids
Teunkens 2016 0/32 (0) — — —
Table 1.   Studies reporting transient neurological symptoms aKer intrathecal lidocaine  (Continued)
N: number of participants; NSAIDs: non-steroidal anti-inflammatory drugs; TNS: transient neurological symptoms; VAS: visual analogue
scale; VPS: verbal pain scale.
 
 
Treatment RR 95% CI 95% PI
bupi 0.19 0.12 to 0.29a 0.12 to 0.30
chloro 0.18 0.02 to 1.53 0.02 to 1.75
levo 0.17 0.04 to 0.70a 0.04 to 0.77
mepi 1.54 0.76 to 3.12 0.73 to 3.27
prilo 0.23 0.10 to 0.55a 0.09 to 0.58
pro 0.17 0.05 to 0.56a 0.05 to 0.60
ropi 0.10 0.01 to 0.78a 0.01 to 0.89
Table 2.   Network meta-analysis, random-e:ects model 
Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical
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bupi: bupivacaine; chloro: 2-chloroprocaine; CI: confidence Interval; levo: levobupivacaine; lido: lidocaine; mepi: mepivacaine; PI:
prediction interval; prilo: prilocaine; pro: procaine, ropi: ropivacaine.
aNull hypothesis of no diDerence rejected.
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95% CI RoR 95% CI z P
val-
ue
bupi:chloro 1 0.32 1.08 0.12 to 9.63 0.92 0.02 to
44.90





bupi:levo 0 0 1.15 0.26 to 5.18 — — 1.15 0.26 to 5.2e+00 — — — —
bupi:lido 12 1.00 0.19 0.12 to 0.29 0.19 0.13 to
0.30
0.00 0.00 to 1.8e+01 42.580.01 to 1.7e
+05
0.89 0.38
bupi:mepi 1 0.09 0.12 0.05 to 0.28 0.04 0.00 to
0.71





bupi:prilo 1 0.09 0.83 0.31 to 2.17 0.33 0.01 to
7.87





bupi:pro 0 0 1.10 0.32 to 3.83 — — 1.10 0.32 to 3.8e+00 — — — —
bupi:ropi 0 0 1.83 0.23 to 14.32 — — 1.83 0.23 to 1.4e+01 — — — —
chloro:levo 0 0 1.06 0.08 to 14.27 — — 1.06 0.08 to 1.4e+01 — — — —
chloro:lido 2 0.90 0.18 0.02 to 1.53 0.21 0.02 to
2.02
0.04 0.00 to 3.8e+01 4.88 0.00 to 6.3e
+03
0.43 0.66
chloro:mepi 0 0 0.11 0.01 to 1.11 — — 0.11 0.01 to 1.1e+00 — — — —
chloro:prilo 0 0 0.76 0.07 to 7.82 — — 0.76 0.07 to 7.8e+00 — — — —
chloro:pro 0 0 1.02 0.09 to 11.87 — — 1.02 0.09 to 1.2e+01 — — — —
chloro:ropi 0 0 1.69 0.09 to 32.35 — — 1.69 0.09 to 3.2e+01 — — — —
levo:lido 2 1.00 0.17 0.04 to 0.70 0.17 0.04 to
0.71
0.00 0.00 to 1.3e+12 266.30.00 to 5.8e
+17
0.31 0.76
levo:mepi 0 0 0.11 0.02 to 0.54 — — 0.11 0.02 to 5.4e-01 — — — —
levo:prilo 0 0 0.72 0.13 to 3.87 — — 0.72 0.13 to 3.9e+00 — — — —



























































































































































































levo:pro 0 0 0.96 0.15 to 6.15 — — 0.96 0.15 to 6.2e+00 — — — —
levo:ropi 1 0.39 1.59 0.14 to 18.08 1.00 0.02 to
48.82





mepi:lido 4 0.97 1.54 0.76 to 3.12 1.47 0.72 to
3.01





prilo:lido 4 1.00 0.23 0.10 to 0.55 0.23 0.10 to
0.55





prop:lido 2 1.00 0.17 0.05 to 0.56 0.17 0.05 to
0.56
— — — — — —
ropi:lido 2 1.00 0.10 0.01 to 0.78 0.10 0.01 to
0.78





mepi:prilo 0 0 6.67 2.18 to 20.44 — — 6.67 2.18 to 2.0e+01 — — — —
mepi:pro 0 0 8.91 2.27 to 34.91 — — 8.91 2.27 to 3.5e+01 — — — —
mepi:ropi 0 0 14.78 1.75 to 124.74 — — 14.78 1.75 to 1.2e+02 — — — —
prilo:pro 0 0 1.34 0.31 to 5.74 — — 1.34 0.31 to 5.7e+00 — — — —
prilo:ropi 0 0 2.21 0.25 to 19.86 — — 2.21 0.25 to 2.0e+01 — — — —
prop:ropi 0 0 1.66 0.16 to 17.03 — — 1.66 0.16 to 1.7e+01 — — — —
Table 3.   Split contributions of direct and indirect evidence in network meta-analysis  (Continued)
bupi: bupivacaine; chloro: 2-chloroprocaine; k: number of studies providing direct evidence; levo: levobupivacaine; lido: lidocaine; mepi: mepivacaine; NA: not available; NMA:
network meta-analysis; pro: direct evidence proportion; prilo: prilocaine; pro: procaine, ropi: ropivacaine; RoR: ratio of ratios (direct versus indirect).
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  Q df P value
Total 18.4 21 0.6232
Within designs 14.8 13 0.3209
Between designs 3.6 8 0.8897
Table 4.   Tests of homogeneity of whole network, homogeneity within designs and homogeneity/inconsistency
between designs 












Table 5.   P score (treatment ranking) 




A P P E N D I C E S
Appendix 1. Search strategy for CENTRAL, the Cochrane Library
#1 MeSH descriptor Lidocaine explode all trees
#2 Lidocain*
#3 MeSH descriptor Anesthesia, Spinal explode all trees
#4 (Spinal near An?esth*)
#5 (#1 OR #2 OR #3 OR #4)
#6 (transient neurologic symptom*) or TNS
#7 transitory radicular irritation
#8 Cauda Equina syndrome
#9 MeSH descriptor Polyradiculopathy, this term only
#10 MeSH descriptor Drug Toxicity, this term only
#11 MeSH descriptor Postoperative Complications, this term only
#12 (#6 OR #7 OR #8 OR #9 OR #10 OR #11)
#13 (#6 AND #12)
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Appendix 2. Search strategy for OvidSP MEDLINE
1 exp Lidocaine/ or (Lidocain* or xylocain* or lignocain*).tw,kw.
2 exp Anesthesia, Spinal/ or ((Spinal or lumbar) adj3 (an?esth* or block*)).tw,kw.
3 1 or 2
4 ((neurologic* adj2 (symptom* or sign* or complication* or syndrome*)) or TNS).tw,kw.
5 Cauda Equina/de, su or Cauda Equina syndrom*.tw,kw.
6 Polyradiculopathy/ or Polyradiculopath*.tw,kw.
7 (transi* radicular irritation* or TRI).tw,kw.
8 Postoperative Complications/
9 "Drug-Related Side EDects and Adverse Reactions"/ or (toxic* adj2 drug*).tw,kw.
10 ((motor block* and (surgery or surgical)) or (return adj4 function*)).tw,kw.
11 4 or 5 or 6 or 7 or 8 or 9 or 10
12 3 and 11
13 ((randomized controlled trial or controlled clinical trial).pt. or random*.ab. or placebo.ab. or clinical trials as topic.sh. or random
allocation.sh. or trial.ti.) not (exp animals/ not humans.sh.)
14 12 and 13
Appendix 3. Search strategy for Elsevier Embase
1 'spinal an*sth*' OR 'lumbar an*sth*' OR 'spinal block'/exp OR 'spinal block' OR 'lumbar block'
2 'local anaesthetic agent'/exp OR 'local an?esth*' OR 'lidocaine'/exp OR 'lidocain*' OR 'lignocain*'
3 'cauda equina syndrome'/exp OR 'cauda equina syndrome' OR 'drug toxicity'/exp OR 'drug toxicity' OR 'postoperative complication'/exp
OR 'postoperative complication' OR transient OR tns OR transitory OR cauda OR 'postoperative randomised controlled trial' OR 'complicat*'
OR 'post-operative complicat*' OR 'drug toxic*'
4 'randomized controlled trial'/exp
5 1 and 2 and 3 and 4
Appendix 4. Search strategy for LILACS (via BIREME interface)
LIDOCAIN or LIDOCAINE or ((Tw anesth$ OR Tw anaesth$) and Tw spinal) or "anestesia espinal" and (Tw postoperativ$ AND Tw complication
$) OR (Tw cauda equina OR Tw "cauda equina sindrome") OR (TW tansit$ AND (Tw radical AND Tw irritation$)) OR "DRUG TOXICITY/" or
(complicação posoperativa) or (complicación postvigente)
Appendix 5. Search strategy for ClinicalTrials.gov
1 'spinal an*sth*' OR 'lumbar an*sth*' OR 'spinal block'/exp OR 'spinal block' OR 'lumbar block'
2 'local anaesthetic agent'/exp OR 'local an?esth*' OR 'lidocaine'/exp OR 'lidocain*' OR 'lignocain*'
3 'cauda equina syndrome'/exp OR 'cauda equina syndrome' OR 'drug toxicity'/exp OR 'drug toxicity' OR 'postoperative complication'/exp
OR 'postoperative complication' OR transient OR tns OR transitory OR cauda OR 'postoperative randomised controlled trial' OR 'complicat*'
OR 'post-operative complicat*' OR 'drug toxic*' OR 'neurologic symptoms' OR 'neurologic outcomes'
4 'randomised controlled trial'/exp
5 1 and 2 and 3 and 4
Appendix 6. Risk of bias
Assessment of random sequence generation
The suDiciency of the method in producing two comparable groups before intervention.
Grading
• Low risk of bias: description of a truly random process in the sequence generation (e.g. random number table, random computer number
generator, coin tossing, shuDling of cards/envelopes, throwing of dice).
• High risk of bias: description of any non-random process in the sequence generation (e.g. date of birth, date of admission, hospital or
clinic record number, judgement of clinician, preference of participant, results of series of tests, availability of the intervention).
• Unclear risk of bias: insuDicient information about the sequence generation process.
Allocation concealment
Allocation method prevented investigators or participants from foreseeing the assignment.
Grading
• Low risk of bias: adequately concealed allocation (e.g. central allocation, sealed envelopes, serially numbered or otherwise convincing
concealment of allocation).
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• High risk of bias: inadequately concealed allocation (e.g. open allocation schedule, unsealed envelopes, alternation of rotation, date
of birth, case record number, other unconcealed procedure).
• Unclear risk of bias: no information on allocation method or no clear distinction of the method.
Blinding of participants and personnel, blinding of outcome assessment
Knowledge of the allocated intervention was adequately prevented during the study.
Grading
• Low risk of bias: adequate blinding in which participants, personnel, and assessor were unaware of intervention allocations aHer
inclusion of participants in the study; or no blinding that is unlikely to introduce bias.
• High risk of bias: inadequate or no blinding (e.g. not double-blind, open-label study, no use of placebo, or an intervention disguised
in the same manner as placebo).
• Unclear risk of bias: insuDicient description of the blinding procedure.
Incomplete outcome data
The completeness of outcome data for each main outcome, including attrition and exclusions from the analysis.
Grading
• Low risk of bias: the numbers and the reasons for dropouts and withdrawals in the intervention groups were described, or it was
specified that no dropouts or withdrawals occurred.
• High risk of bias: no description of dropouts and withdrawals was provided.
• Unclear risk of bias: the report gave the impression that no dropouts or withdrawals occurred, but this was not specifically stated.
Selective reporting
The possibility of selective outcome reporting.
Grading
• Low risk of bias: the reported outcomes were those prespecified in an available study protocol, or, if this was not available, the published
report included all expected outcomes.
• High risk of bias: not all prespecified outcomes were reported, or they were reported using subscales that were not prespecified, or they
were reported incompletely or failed to include a key outcome that would be expected to have been reported for such a study.
• Unclear risk of bias: it was not clear whether all predefined or clinically relevant and reasonably expected outcomes were reported or
were not reported fully, or it was unclear whether data on these outcomes were recorded.
Appendix 7. Network meta-analysis
Original data (with adjusted standards for multiarm studies)
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Study treat1 treat2 TE seTE seTE.adj narms multiarm
Ali Hassan 2015 bupi lido 0.00 1.9807 1.198 2 —
Aouad 2001 bupi lido 0.00 1.9950 2.00 2 —
Etezadi 2013 bupi lido –1.77 0.2545 0.25 2 —
Hampl 1995a bupi lido –2.41 1.4184 1.42 2 —
Hampl 1998 bupi lido –2.94 1.4285 1.51 3 *
Imbelloni 2010 bupi lido 0.00 1.9934 1.99 2 —
Keld 2000 bupi lido –1.85 0.8464 0.85 2 —
Philip 2001 bupi lido 0.58 1.0000 1.00 2 —
Pollock 1996 bupi lido –2.78 1.4257 1.43 2 —
Pradhan 2010 bupi lido 0.00 1.9814 1.43 2 —
Salmela 1998 bupi lido –2.56 1.4455 2.54 3 *
Teunkens 2016 bupi lido –0.09 1.9854 2.43 3 *
Casati 2007 chloro lido –2.40 1.4342 1.43 2 —
Teunkens 2016 chloro lido 0.00 1.9848 2.43 3 *
Breebaart 2003 levo lido –1.95 1.4904 1.57 3 *
Gozdemir 2010 levo lido –1.73 0.8484 0.85 2 —
Liguori 1998 lido mepi 2.67 1.4443 1.44 2 —
Pawlowski 2012 lido mepi –0.08 1.9875 1.99 2 —
Salazar 2001 lido mepi –0.85 0.9506 0.95 2 —




























































































































































































de Weert 2000 lido prilo 2.71 1.4414 1.44 2 —
Hampl 1998 lido prilo 1.85 0.8411 0.85 3 *
Martinez-Bourio 1998 lido prilo 1.14 0.9322 0.93 2 —
Østgaard 2000 lido prilo 1.12 0.7027 0.70 2 —
Hodgson 2000 lido pro 1.53 0.6568 0.66 2 —
Le Truong 2001 lido pro 2.83 1.4329 1.43 2 —
Breebaart 2003 lido ropi 1.95 1.4904 1.57 3 *
Fanelli 2009 lido ropi 2.56 1.4244 1.42 2 —
Salmela 1998 bupi mepi –3.14 1.4221 1.71 3 *
Hampl 1998 bupi prilo –1.10 1.6131 4.44 3 *
Breebaart 2003 levo ropi 0.00 1.9838 4.38 3 *
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Treat1, Treat2: bupi: bupivacaine; chloro: 2-chloroprocaine; levo: levobupivacaine; lido: lidocaine; mepi: mepivacaine; prilo: prilocaine;
pro: procaine; ropi: ropivacaine.
multiarm: studies with more than two arms; narms: number of study arms; seTE: log(RR)SE; seTE.adj: adjusted seTE; TE: log(RR).
W H A T ' S   N E W
 
Date Event Description
3 December 2019 Amended Resolution of several figures updated.
 
H I S T O R Y
Protocol first published: Issue 2, 2001
Review first published: Issue 2, 2003
 
Date Event Description
25 November 2018 New search has been performed Change in authors; the previous published version was authored
by Zaric D, Christiansen C, Pace NL, Punjasawadwong Y (Zaric
2005).
This updated version is authored by Forget P, Borovac JA, Thack-
eray EM, Pace NL.
We modified the Embase search strategy and ran it in Elsevier
Embase for 2008 to 2016. We edited Appendix 3 to show our re-
vised search strategy.
We searched to 25 November 2018.
We included eight new studies in this updated version (Etezadi
2013; Fanelli 2009; Gozdemir 2010; Ali Hassan 2015; Imbelloni
2010; Pawlowski 2012; Pradhan 2010; Teunkens 2016). Two stud-
ies are awaiting classification (Frisch 2018; Gozdemir 2016); and
one is ongoing (Gozdemir 2016).
We undertook a network meta-analysis.
We added full risk of bias tables. We added a 'Summary of find-
ings' table.
25 November 2018 New citation required but conclusions
have not changed
The conclusions are not changed by the inclusion of the eight
new studies.
24 November 2008 New search has been performed Searches rerun until August 2008.
One new randomized controlled trial was included that com-
pared 2-chloroprocaine to lidocaine (Casati 2007). This new
study does not change the results. Eight new references have
been added to the Additional references (Kopacz 2005; Moore
1982; Reisner 1980; Sell 2008; Smith 2004; Winnie 2001; Yoos
2005).
24 November 2008 New search has been performed Change in authors; the previous published version was authored
by Zaric D, Christiansen C, Pace NL, Punjasawadwong Y (Zaric
2005).
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Date Event Description
This updated version is authored by Forget P, Borovac JA, Thack-
eray EM, Pace NL.
2 July 2008 Amended Converted to new review format.
2 August 2005 New search has been performed This review was first updated in Issue 4, 2005. The literature
search for this updated review resulted in the inclusion of one
further randomized controlled trial (Breebaart 2003). The occur-
rence of transient neurological symptoms (TNS) after intrathecal
lidocaine was compared to that after two new local anaesthetics:
levobupivacaine and ropivacaine. This addition did not change
the results of this review.
Three new references have been added to the review: one in the
Included studies tables (Breebaart 2003), one in the Excluded
studies tables (Tong 2003), and one to the Additional references
(Freedman 1998).
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